Therapeutic targets of vitamin D receptor ligands and their pharmacokinetic effects by modulation of transporters and metabolic enzymes

Vitamin D is involved in retaining the balance of several minerals in the body, such as calcium and phosphate, which are crucial for the bone formation and development. These physiological effects of vitamin D are mediated by activation of the transcription factor vitamin D receptor (VDR). Moreover,...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical investigation Vol. 50; no. 1; pp. 1 - 16
Main Authors Choi, Min Sik, Kim, Yu Chul, Maeng, Han-Joo
Format Journal Article
LanguageEnglish
Published Singapore Springer Singapore 01.01.2020
한국약제학회
Subjects
Online AccessGet full text
ISSN2093-5552
2093-6214
DOI10.1007/s40005-019-00429-z

Cover

Abstract Vitamin D is involved in retaining the balance of several minerals in the body, such as calcium and phosphate, which are crucial for the bone formation and development. These physiological effects of vitamin D are mediated by activation of the transcription factor vitamin D receptor (VDR). Moreover, vitamin D is closely related to several pathological conditions including osteoporosis, secondary hyperparathyroidism, cancer, psoriasis and autoimmune diseases, which is not only due to calcemic but also non-calcemic effects of vitamin D such as cell proliferation, differentiation, and immunomodulation. These various abilities of vitamin D have made VDR an attractive therapeutic target. Already, numerous vitamin D analogs have been developed and studied in in vitro disease models or animal models, and some have been in clinical trials or approved for the treatment of certain diseases. In addition, the transcriptional and/or post-transcriptional regulation by VDR activation also affects the genes involved in drug metabolism and disposition, possibly leading to pharmacokinetic changes of several drugs in clinical use. This review provides a detailed summary of therapeutic targets of VDR ligands, and their effects on the transporters and metabolic enzymes, causing in vitro and in vivo pharmacokinetic changes of several drugs. The clinical research is further required for the confirming the clinical relevance of pharmacokinetic drug interactions by VDR ligands.
AbstractList Vitamin D is involved in retaining the balance of several minerals in the body, such as calcium and phosphate, which are crucial for the bone formation and development. These physiological effects of vitamin D are mediated by activation of the transcription factor vitamin D receptor (VDR). Moreover, vitamin D is closely related to several pathological conditions including osteoporosis, secondary hyperparathyroidism, cancer, psoriasis and autoimmune diseases, which is not only due to calcemic but also non-calcemic effects of vitamin D such as cell proliferation, differentiation, and immunomodulation. These various abilities of vitamin D have made VDR an attractive therapeutic target. Already, numerous vitamin D analogs have been developed and studied in in vitro disease models or animal models, and some have been in clinical trials or approved for the treatment of certain diseases. In addition, the transcriptional and/or post-transcriptional regulation by VDR activation also affects the genes involved in drug metabolism and disposition, possibly leading to pharmacokinetic changes of several drugs in clinical use. This review provides a detailed summary of therapeutic targets of VDR ligands, and their effects on the transporters and metabolic enzymes, causing in vitro and in vivo pharmacokinetic changes of several drugs. The clinical research is further required for the confirming the clinical relevance of pharmacokinetic drug interactions by VDR ligands. KCI Citation Count: 7
Vitamin D is involved in retaining the balance of several minerals in the body, such as calcium and phosphate, which are crucial for the bone formation and development. These physiological effects of vitamin D are mediated by activation of the transcription factor vitamin D receptor (VDR). Moreover, vitamin D is closely related to several pathological conditions including osteoporosis, secondary hyperparathyroidism, cancer, psoriasis and autoimmune diseases, which is not only due to calcemic but also non-calcemic effects of vitamin D such as cell proliferation, differentiation, and immunomodulation. These various abilities of vitamin D have made VDR an attractive therapeutic target. Already, numerous vitamin D analogs have been developed and studied in in vitro disease models or animal models, and some have been in clinical trials or approved for the treatment of certain diseases. In addition, the transcriptional and/or post-transcriptional regulation by VDR activation also affects the genes involved in drug metabolism and disposition, possibly leading to pharmacokinetic changes of several drugs in clinical use. This review provides a detailed summary of therapeutic targets of VDR ligands, and their effects on the transporters and metabolic enzymes, causing in vitro and in vivo pharmacokinetic changes of several drugs. The clinical research is further required for the confirming the clinical relevance of pharmacokinetic drug interactions by VDR ligands.
Author Maeng, Han-Joo
Choi, Min Sik
Kim, Yu Chul
Author_xml – sequence: 1
  givenname: Min Sik
  surname: Choi
  fullname: Choi, Min Sik
  organization: Lab of Pharmacology, College of Pharmacy, Dongduk Women’s University
– sequence: 2
  givenname: Yu Chul
  surname: Kim
  fullname: Kim, Yu Chul
  email: yckim@inje.ac.kr
  organization: Department of Pharmaceutical Engineering, Inje University
– sequence: 3
  givenname: Han-Joo
  surname: Maeng
  fullname: Maeng, Han-Joo
  email: hjmaeng@gachon.ac.kr
  organization: College of Pharmacy, Gachon University
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002552342$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kLtu3DAQRYnABuI4_gFXbF0o4UOipNKw8zBgIECwPTFLDXfplUiB5AbY_YH8dijLVQo3c6e4Z4A5n8iFDx4JueXsC2es_ZpqxlhTMd5XjNWir84fyJVgvayU4PXF2940jfhIblJ6YUtd8a7rr8jfzR4jzHjMztAMcYc50WDpH5dhcp4-0ogG5xwiHd0O_JBoGTTv0UU67yFOYMLBeVx4tBZN4bcnOoXhOEJ2wS_XcgSf5hAzxpWfMMM2jAvjz6cJ02dyaWFMePOW12Tz_dvm4Wf1_OvH08P9c2WkaHI1AAjVKs7Bbo2FrhuwFzUHaZSAvhuMrU3bMokdGmk63qqtbK2sTaOgaUBek7v1rI9WH4zTAdxr7oI-RH3_e_OklSpSW1m63do1MaQU0WpTpCwvlXfcqDnTi3696tdFv37Vr88FFf-hc3QTxNP7kFyhVMp-h1G_hGP0xcZ71D93HZ5L
CitedBy_id crossref_primary_10_3390_pharmaceutics12111129
crossref_primary_10_1007_s40005_023_00659_2
crossref_primary_10_3390_ijms24098166
crossref_primary_10_3390_pharmaceutics12030264
crossref_primary_10_1007_s40005_022_00563_1
crossref_primary_10_1007_s40005_022_00600_z
crossref_primary_10_1016_j_ejps_2023_106396
crossref_primary_10_1007_s40005_021_00538_8
crossref_primary_10_3390_genes14010193
Cites_doi 10.1056/NEJM197205182862009
10.1001/jama.281.16.1505
10.1159/000322008
10.1210/er.2001-8002
10.1001/archopht.120.5.607
10.1210/endo.143.7.8887
10.1002/jps.22366
10.1016/S0006-291X(02)02742-0
10.2133/dmpk.DMPK-11-RG-089
10.1210/jc.2008-0784
10.3389/fonc.2014.00125
10.1210/endo-108-3-1083
10.1002/bdd.1856
10.1172/JCI114229
10.1073/pnas.202471299
10.1002/jbmr.256
10.1093/ndt/gfh329
10.4161/cc.23846
10.1111/j.1365-2133.1989.tb01353.x
10.1016/j.chembiol.2013.12.016
10.1159/000346846
10.4161/cc.24445
10.1182/blood-2002-07-1984
10.1053/j.gastro.2011.11.040
10.1124/dmd.113.055673
10.1002/jnr.490370212
10.1161/STROKEAHA.107.513655
10.1016/S0960-0760(99)00112-0
10.1007/s11060-007-9418-z
10.1097/PPO.0b013e3181c51ee6
10.1002/jcb.10346
10.1111/j.1753-4887.2008.00105.x
10.1016/j.bcp.2006.04.033
10.1016/j.jsbmb.2010.03.053
10.1016/S0022-2143(99)90004-5
10.1016/j.ejps.2009.01.006
10.1002/ijc.26279
10.1007/s10620-010-1544-3
10.1248/bpb.b15-00356
10.1002/cncr.25059
10.1046/j.1365-2133.1999.02975.x
10.1016/0272-6386(95)90455-7
10.3390/nu5072502
10.1002/jcb.22661
10.1124/mol.51.5.741
10.1124/mol.65.3.720
10.1111/j.1600-0625.2007.00570.x
10.1053/gast.1996.v110.pm8613068
10.1210/endo.143.5.8777
10.1111/j.1432-1033.1995.tb20727.x
10.3346/jkms.2012.27.9.1037
10.1124/dmd.116.070300
10.3389/fphys.2014.00213
10.1053/ajkd.1998.v32.pm9808145
10.1210/endo.139.3.5770
10.1038/sj.jid.5700692
10.1111/1523-1747.ep12480255
10.1016/j.jsbmb.2013.02.005
10.1074/jbc.M308430200
10.1074/jbc.M010101200
10.1111/ijd.12790
10.1007/s00246-012-0199-6
10.1124/jpet.108.149815
10.1182/blood.V93.7.2225
10.1592/phco.29.6.691
10.1016/S0090-4295(97)00408-1
10.1210/me.2011-1109
10.1093/jnci/89.3.182
10.1016/0006-2952(92)90405-8
10.1007/s10157-005-0363-x
10.1016/j.jsbmb.2006.12.098
10.1007/s00774-006-0738-4
10.1111/j.1365-2133.1996.tb07608.x
10.1046/j.1365-2133.2001.04075.x
10.1177/1352458513494959
10.1124/jpet.107.127209
10.1016/j.jsbmb.2005.06.002
10.1016/S0021-9258(18)61537-6
10.1038/bjc.1997.501
10.1172/JCI113010
10.1074/jbc.M201323200
10.1007/s00198-008-0650-y
10.1093/ajcn/79.3.362
10.1210/endo.133.6.8243296
10.1124/mol.110.068403
10.1007/BF01623386
10.1002/bdd.682
10.1093/ndt/17.suppl_10.41
10.1093/carcin/bgh332
10.1016/j.ejps.2012.02.018
10.1124/jpet.111.179101
10.1159/000420143
10.1046/j.1523-1755.1999.055003821.x
10.3389/fphys.2014.00122
10.1093/jnci/95.12.896
10.1177/1756285612447090
10.1046/j.1523-1755.2003.00029.x
10.1053/ajkd.2003.50097
10.1194/jlr.M044420
10.3899/jrheum.111594
10.1159/000371350
10.1681/ASN.V981427
10.1124/mol.60.6.1399
10.1093/ajcn/83.4.754
10.1002/jps.24195
10.1210/endo.141.6.7515
10.4161/cc.5.4.2467
10.1002/bdd.742
10.1046/j.1523-1755.1999.00575.x
10.1093/carcin/bgm094
10.1007/s00198-003-1570-5
10.1016/0006-291X(91)91333-8
10.1016/S0022-5347(01)63098-2
10.1038/clpt.2008.165
10.1111/j.1774-9987.2004.00191.x
10.4161/derm.17534
10.1016/j.jneuroim.2015.01.005
10.1152/ajpendo.00224.2004
10.1111/j.1523-1755.2004.00432.x
10.1159/000323941
10.1124/mol.105.020792
10.1097/01.ASN.0000093255.56474.B4
10.1016/j.jsbmb.2006.12.099
10.1124/mol.105.019851
10.1001/archopht.122.9.1357
10.1111/j.1472-8206.2011.00944.x
10.1038/nrrheum.2010.86
10.1158/1535-7163.373.3.3
10.1007/s003930070034
10.1124/mol.112.077909
10.1053/j.ajkd.2004.01.012
10.1158/1535-7163.MCT-09-0064
10.1046/j.1365-2133.2002.04567.x
10.1016/j.trsl.2016.07.006
10.1038/onc.2008.88
10.1093/jn/133.7.2425S
10.1158/0008-5472.CAN-08-2307
10.1126/science.1070477
10.1002/cncr.25478
10.1111/j.0022-202X.2004.22424.x
10.1002/bdd.694
10.1359/JBMR.050605
10.4161/cbt.7.3.5418
10.1111/j.1365-2133.1988.tb03204.x
10.1002/bdd.2118
10.2147/TCRM.S3552
10.1074/jbc.M411520200
10.1111/j.1600-0625.2004.00257.x
10.1161/01.RES.87.3.214
10.1093/ndt/17.suppl_10.28
10.1161/CIRCULATIONAHA.107.706127
10.1016/j.ejps.2012.11.008
10.1556/EuJMI.3.2013.4.1
10.1016/j.jsbmb.2006.12.081
10.1016/0140-6736(91)92157-W
10.1016/S0303-7207(00)00226-4
10.1074/jbc.M311052200
ContentType Journal Article
Copyright The Korean Society of Pharmaceutical Sciences and Technology 2019
Copyright_xml – notice: The Korean Society of Pharmaceutical Sciences and Technology 2019
DBID AAYXX
CITATION
ACYCR
DOI 10.1007/s40005-019-00429-z
DatabaseName CrossRef
Korean Citation Index
DatabaseTitle CrossRef
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
EISSN 2093-6214
EndPage 16
ExternalDocumentID oai_kci_go_kr_ARTI_6600773
10_1007_s40005_019_00429_z
GrantInformation_xml – fundername: Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning
  grantid: NRF-2016R1D1A1B03931470
GroupedDBID -EM
.UV
06D
0R~
0VY
203
29~
30V
4.4
406
408
96X
9ZL
AAAVM
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAZMS
ABAKF
ABDZT
ABECU
ABFTV
ABJNI
ABJOX
ABKCH
ABMQK
ABPLI
ABQBU
ABTEG
ABTHY
ABTKH
ABTMW
ABXPI
ACAOD
ACCUX
ACDTI
ACGFS
ACHSB
ACKNC
ACMLO
ACOKC
ACPIV
ACZOJ
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGNC
AEJHL
AEJRE
AEMSY
AEOHA
AEPYU
AESKC
AETCA
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKLTO
AKMHD
ALFXC
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMXSW
AMYLF
AMYQR
ANMIH
AUKKA
AXYYD
BGNMA
CSCUP
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
ESBYG
FERAY
FIGPU
FINBP
FNLPD
FRP
FRRFC
FSGXE
FYJPI
GGCAI
GGRSB
GJIRD
GQ6
GQ7
HMJXF
HRMNR
HZ~
I0C
IKXTQ
IWAJR
IXD
J-C
JBSCW
JDI
JZLTJ
KOV
LLZTM
M4Y
NPVJJ
NQJWS
NU0
O9-
O9J
PT4
RLLFE
ROL
RSV
S3A
SBL
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
TSG
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
Z7U
Z87
ZMTXR
ZOVNA
~A9
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
ACYCR
ID FETCH-LOGICAL-c325t-daa267611afbcfa88de9241a3c62a98dcf4c7703e8ec3c8176b37f34c56a55a3
IEDL.DBID AGYKE
ISSN 2093-5552
IngestDate Sun Mar 09 07:51:16 EDT 2025
Tue Jul 01 01:09:53 EDT 2025
Thu Apr 24 23:00:14 EDT 2025
Fri Feb 21 02:37:05 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Vitamin D receptor (VDR)
Transporters
Vitamin D
Pharmacokinetics
Metabolic enzymes
Therapeutic target
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c325t-daa267611afbcfa88de9241a3c62a98dcf4c7703e8ec3c8176b37f34c56a55a3
PageCount 16
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_6600773
crossref_citationtrail_10_1007_s40005_019_00429_z
crossref_primary_10_1007_s40005_019_00429_z
springer_journals_10_1007_s40005_019_00429_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20200100
2020-01-00
2020-01
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 1
  year: 2020
  text: 20200100
PublicationDecade 2020
PublicationPlace Singapore
PublicationPlace_xml – name: Singapore
PublicationTitle Journal of pharmaceutical investigation
PublicationTitleAbbrev J. Pharm. Investig
PublicationYear 2020
Publisher Springer Singapore
한국약제학회
Publisher_xml – name: Springer Singapore
– name: 한국약제학회
References Fujioka, Hasegawa, Ishikura, Matsushita, Sato, Tanji (CR51) 1998; 160
Shapira, Agmon-Levin, Shoenfeld (CR137) 2010; 6
Wang, Pencina, Booth, Jacques, Ingelsson, Lanier, Benjamin, D’Agostino, Wolf, Vasan (CR159) 2008; 117
Pilz, März, Wellnitz, Seelhorst, Fahrleitner-Pammer, Dimai, Boehm, Dobnig (CR122) 2008; 93
Nishizawa, Morii, Ogura, De Luca (CR111) 1991; 90
Holick, Chen, Kong, Sanan (CR64) 1996; 1
Getzenberg, Light, Lapco, Konety, Nangia, Acierno, Dhir, Shurin, Day, Trump, Johnson (CR53) 1997; 50
Goto, Komaba, Fukagawa (CR55) 2008; 1
Yoon, Son, Kim, Choi, Maeng (CR169) 2015; 38
van Ginkel, Yang, Marcet, Chow, Kulkarni, Darjatmoko, Lindstrom, Lokken, Bhattacharya, Albert (CR154) 2007; 85
Kota, Abdul, Allen, Kalagara, Roufogalis (CR72) 2012; 26
Shedeed (CR138) 2012; 33
Drocourt, Ourlin, Pascussi, Maurel, Vilarem (CR42) 2002; 277
Meyer, Goetsch, Pike (CR98) 2012; 26
Pilz, Dobnig, Fischer, Wellnitz, Seelhorst, Boehm, März (CR121) 2008; 39
Kumagai, O’Kelly, Said, Koeffler (CR76) 2003; 95
Eloranta, Hiller, Jüttner, Kullak-Ublick (CR47) 2012; 82
Wang, Wang, Shen, Overholser, Cooper, Lu, Tang, Zhou, Sun, Zhong, Favus, Decker, Liu, Peng (CR160) 2016; 178
Yudoh, Matsuno, Kimura (CR170) 1999; 133
Chow, Durk, Maeng, Pang (CR31) 2013; 34
Nakagawa, Kawaura, Kato, Takeda, Okano (CR105) 2005; 26
DeLuca, Bedale, Binkley, Gallagher, Bolognese, Peacock, Aloia, Clagett-Dame, Plum (CR40) 2011; 26
Cheng, Fang, Kim, Krausz, Tanaka, Chiang, Gonzalez (CR25) 2014; 55
Grostern, Bryar, Zimbric, Darjatmoko, Lissauer, Lindstrom, Lokken, Strugnell, Albert (CR56) 2002; 120
Slatopolsky, Cozzolino, Lu, Finch, Dusso, Staniforth, Wein, Webster (CR142) 2003; 63
Chow, Sun, Khan, Groothuis, Pang (CR28) 2010; 31
Ke, Qi, Crawford, Simmons, Xu, Li, Plum, Clagett-Dame, DeLuca, Thompson, Brown (CR69) 2005; 20
Naveh-Many, Silver (CR107) 1993; 133
Slatopolsky, Finch, Ritter, Denda, Morrissey, Brown, DeLuca (CR141) 1995; 26
Trémezaygues, Reichrath (CR151) 2011; 3
McCarthy, Li, Sinal (CR96) 2005; 280
Shevde, Plum, Clagett-Dame, Yamamoto, Pike, DeLuca (CR139) 2002; 99
Mantell, Owens, Bundred, Mawer, Canfield (CR91) 2000; 87
Bener, Ehlayel, Tulic, Hamid (CR13) 2012; 157
Bhatia, Saini, Shen, Bi, Qiu, Weigel, Falzon (CR15) 2009; 8
Aguilera, Peña, García, Larriba, Ordóñez-Morán, Navarro, Barbáchano, López de Silanes, Ballestar, Fraga, Esteller, Gamallo, Bonilla, González-Sancho, Muñoz (CR3) 2007; 28
Trump, Deeb, Johnson (CR152) 2010; 16
Monier-Faugere, Geng, Friedler, Qi, Kubodera, Slatopolsky, Malluche (CR102) 1999; 55
Zierold, Mings, Deluca (CR174) 2006; 69
Coburn, Maung, Elangovan, Germain, Lindberg, Sprague, Williams, Bishop (CR33) 2004; 43
Hayashi, Tsuchiya, Itaya, Takenaka, Kobayashi, Yoshizawa, Nakamura, Monkawa, Ichihara (CR61) 2004; 19
Thummel, Brimer, Yasuda, Thottassery, Senn, Lin, Ishizuka, Kharasch, Schuetz, Schuetz (CR149) 2001; 60
Wang, Jones, Studzinski (CR158) 1996; 56
Zhuang, Burnstein (CR173) 1998; 139
Miao, Liu, Wang, Meng, Guo, Sun, Peng, Ma, Kaku, Liu (CR99) 2013; 48
Hara, Kusuzaki, Takeshita, Kuzuhara, Tsuji, Ashihara, Hirasawa (CR59) 2001; 21
Imanishi, Inaba, Seki, Koyama, Nishizawa, Morii, Otani (CR65) 1999; 70
Schwartz, Wang, Zang, Singh, Siegal (CR134) 1997; 6
Beer, Myrthue (CR11) 2004; 3
Weishaar, Simpson (CR162) 1987; 79
Wöbke, Sorg, Steinhilber (CR165) 2014; 5
van de Kerkhof, van Bokhoven, Zultak, Czarnetzki (CR155) 1989; 120
Bernardi, Johnson, Modzelewski, Trump (CR14) 2002; 143
Zhang, Zhang, Studzinski (CR171) 2006; 5
Bikle, Chang, Crumrine, Elalieh, Man, Choi, Dardenne, Xie, Arnaud, Feingold, Elias (CR17) 2004; 122
Colston, Colston, Feldman (CR34) 1981; 108
Echchgadda, Song, Roy, Chatterjee (CR45) 2004; 65
Lemire (CR80) 2000; 59
Rondini, Fang, Runge-Morris, Kocarek (CR128) 2014; 42
Kubodera, Tsuji, Uchiyama, Endo (CR75) 2003; 88
Barker, Ashton, Marks, Harris, Berth-Jones (CR9) 1999; 141
Khan, Chow, van Loenen-Weemaes, Porte, Pang, Groothuis (CR70) 2009; 37
Milde, Hauser, Simon, Mall, Ernst, Haussler, Frosch, Rauterberg (CR100) 1991; 97
Bricker (CR19) 1972; 286
Pèrez, Chen, Turner, Raab, Bhawan, Poche, Holick (CR119) 1996; 134
Nemerovski, Dorsch, Simpson, Bone, Aaronson, Bleske (CR109) 2009; 29
Guzey, Kitada, Reed (CR58) 2002; 1
Maeng, Chapy, Zaman, Pang (CR88) 2012; 46
Fujita, Orimo, Inoue, Kaneda, Sakurai, Morita, Yamamoto, Sugioka, Inoue, Takaoka, Yamamoto, Hoshino, Kawaguchi (CR52) 2007; 25
Thompson, Jurutka, Whitfield, Myskowski, Eichhorst, Dominguez, Haussler, Haussler (CR148) 2002; 299
Abou-Raya, Abou-Raya, Helmii (CR1) 2013; 40
Ananthakrishnan, Khalili, Higuchi, Bao, Korzenik, Giovannucci, Richter, Fuchs, Chan (CR8) 2012; 142
Chow, Durk, Cummins, Pang (CR29) 2011; 337
van de Kerkhof, Berth-Jones, Griffiths, Harrison, Hönigsmann, Marks, Roelandts, Schöpf, Trompke (CR156) 2002; 146
Leyssens, Verlinden, Verstuyf (CR82) 2014; 5
Brown, Ritter, Finch, Morrissey, Martin, Murayama, Nishii, Slatopolsky (CR20) 1989; 84
Park, Lee, Park, Hwang, Shim, Cho, Chung, Bae (CR115) 2012; 27
Francis, Boyle, Moniz, Sutcliffe, Davis, Beastall, Cowan, Downes (CR50) 1996; 6
Chiang, Yeh, Hsu, Yeh, Jan, Wu, Chen, Jwo, Takano, Kittaka, Juang, Chen (CR26) 2013; 15
Xiang, Kong, Chen, Cao, Qiao, Zheng, Liu, Li, Gardner, Li (CR166) 2005; 288
Durakovic, Malabanan, Holick (CR43) 2001; 144
Akizawa, Suzuki, Akiba, Nishizawa, Ohashi, Ogata, Slatopolsky, Kurokawa (CR5) 2002; 17
Schleithoff, Zittermann, Tenderich, Berthold, Stehle, Koerfer (CR131) 2006; 83
Guo, Meng, Liu, Wang, Mao, Sun, Peng, Kaku, Liu (CR57) 2012; 27
McGuire, Trump, Johnson (CR97) 2001; 276
Quach, Noh, Hoi, Bruinsma, Groothuis, Li, Chow, Pang (CR124) 2018; 39
Albert, Kumar, Strugnell, Darjatmoko, Lokken, Lindstrom, Patel (CR7) 2004; 122
Li, Peng, Jiang, Sun, Zhang, Lian, Litonjua, Gao, Gao (CR84) 2011; 81
Lee, So, DeCastro, Smolarek, Paul, Maehr, Uskokovic, Suh (CR78) 2010; 121
Muto, Kizaki, Yamato, Kawai, Kamata-Matsushita, Ueno, Ohguchi, Nishihara, Koeffler, Ikeda (CR104) 1999; 93
Sunyecz (CR146) 2008; 4
Naveilhan, Berger, Haddad, Barbot, Benabid, Brachet, Wion (CR108) 1994; 37
Schwartz, Eads, Naczki, Northrup, Chen, Koumenis (CR135) 2008; 7
Pierrot-Deseilligny, Rivaud-Péchoux, Clerson, de Paz, Souberbielle (CR120) 2012; 5
Xu, Iwanaga, Zhou, Cheesman, Farin, Thummel (CR167) 2006; 28
Simpson, Hershey, Nibbelink (CR140) 2007; 103
Soleymani, Hung, Soung (CR144) 2015; 54
Bikle (CR16) 2014; 21
DeLuca (CR39) 2008; 66
Makishima, Lu, Xie, Whitfield, Domoto, Evans, Haussler, Mangelsdorf (CR90) 2002; 17
Ma, Yu, Trump, Johnson (CR85) 2010; 116
Pendás-Franco, García, Peña, Valle, Pálmer, Heinäniemi, Carlberg, Jiménez, Bonilla, Muñoz, González-Sancho (CR117) 2008; 27
Torres, García, Gómez, González, Barrios, Concepción, Hernández, García, Checa, Lorenzo, Salido (CR150) 2004; 65
Fan, Liu, Du, Morrison, Shipman, Pang (CR48) 2009; 330
Chow, Durk, Maeng, Pang (CR27) 2009; 30
Hargrove, Francis, Francis (CR60) 2014; 2
Seubwai, Wongkham, Puapairoj, Okada, Wongkham (CR136) 2010; 116
Welsh, Wietzke, Zinser, Byrne, Smith, Narvaez (CR164) 2003; 133
van Etten, Mathieu (CR153) 2005; 97
Yasuda, Akiba, Nihei (CR168) 2003; 41
Colston, Chander, Mackay, Coombes (CR35) 1992; 44
Marchwicka, Cebrat, Sampath, Snieżewski, Marcinkowska (CR92) 2014; 4
Barrett, Fang, Kocarek, Runge-Morris (CR10) 2016; 44
Chen, Chen, Liu, Glaeser, Dawson, Hofmann, Kim, Shneider, Pang (CR24) 2006; 69
Hirata, Endo, Katsumata, Ichikawa, Kubodera, Fukagawa (CR62) 2002; 17
Tamura, Ueki, Mashimo, Tsukada, Naitoh, Abe, Kawai, Tsuchida, Wakamatsu, Nojima (CR147) 2005; 9
Katayama, Ohkawara, Ohkido, Harada, Tamaki, Nakagawa, Hori, Nishiyama (CR67) 2002; 12
Ma, Yu, Hidalgo, Luo, Delansorne, Johnson, Trump (CR86) 2013; 12
Richy, Ethgen, Bruyere, Reginster (CR127) 2004; 15
Kragballe, Gjertsen, De Hoop, Karlsmark, van de Kerkhof, Larkö, Nieboer, Roed-Petersen, Strand, Tikjøb (CR74) 1991; 337
Lehmann, Querings, Reichrath (CR79) 2004; 4
Martinelli, Dalla Costa, Colombo, Dalla Libera, Rubinacci, Filippi, Furlan, Comi (CR95) 2014; 20
Zhang, Shih, Zhang (CR172) 2013; 3
Campbell, Koeffler (CR22) 1997; 89
Pálmer, Sánchez-Carbayo, Ordóñez-Morán, Larriba, Cordón-Cardó, Muñoz (CR113) 2003; 63
Kim, Kim, Noh, Quach, Yoon, Chow, Kim, Jin, Cho, Chung, Pang, Maeng (CR71) 2014; 103
Brown, Finch, Lopez-Hilker, Dusso, Ritter, Pernalete, Slatopolsky (CR21) 1990; 29
Sung, Feldman (CR145) 2000; 164
Colston, James, Ofori-Kuragu, Binderup, Grant (CR36) 1997; 76
Daniel, Sartory, Zahn, Radeke, Stein (CR38) 2008; 324
Kawa, Yoshizawa, Tokoo, Imai, Oguchi, Kiyosawa, Homma, Nikaido, Furihata (CR68) 1996; 110
So, Lee, Smolarek, Paul, Wang, Maehr, Uskokovic, Zheng, Conney, Cai, Liu, Suh (CR143) 2011; 79
Bell, Demay, Burnett-Bowie (CR12) 2010; 111
Cross, Huber, Peterlik (CR37) 1991; 179
Narvaez, Matthews, LaPorta, Simmons, Beaudin, Welsh (CR106) 2014; 5
Maeng, Durk, Chow, Ghoneim, Pang (CR87) 2011; 32
Pepper, Thomas, Hoy, Milligan, Bentley, Fegan (CR118) 2003; 101
Walters, Ilenchuk, Claycomb (CR157) 1987; 262
Di Filippo, Scaparrotta, Rapino, Cingolani, Attanasi, Petrosino, Chuang, Di Pillo, Chiarelli (CR41) 2015; 166
Akizawa, Ohashi, Akiba, Suzuki, Nishizawa, Ogata, Slatopolsky, Kurokawa (CR6) 2004; 8
Jiang, Li, Fornace, Nicosia, Bai (CR66) 2003; 278
Schwartz (CR133) 2009; 85
El-Agroudy, El-Husseini, El-Sayed, Ghoneim (CR46) 2003; 14
Schmiedlin-Ren, Thummel, Fisher, Paine, Lown, Watkins (CR132) 1997; 51
Peleg, Uskokovic, Ahene, Vickery, Avnur (CR116) 2002; 143
Ghous, Akhter, Pourgholami, Morris (CR54) 2008; 28
Reichrath (CR126) 2007; 16
Nibbelink, Tishkoff, Hershey, Rahman, Simpson (CR110) 2007; 103
Rahman, Hershey, Ahmed, Nibbelink, Simpson (CR125) 2007; 103
Levin, Wadhera, Leach, Woodhead, Lemberg, Mendoza-Cruz, Day (CR81) 2011; 56
Bollag (CR18) 2007; 127
Morán-Auth, Penna-Martinez, Shoghi, Ramos-Lopez, Badenhoop (CR103) 2013; 136
Duranton, Rodriguez-Ortiz, Duny, Rodriguez, Daurès, Argilés (CR44) 2013; 37
Kragballe, Beck, Søgaard (CR73) 1988; 119
Åivo, Hänninen, Ilonen, Soilu-Hänninen (CR4) 2015; 280
Martin, Gonzales, Gellens, Hamm, Abboud, Lindberg (CR93) 1998; 9
Prietl, Treiber, Pieber, Amrein (CR123) 2013; 5
Holick (CR63) 2004; 79
Adami, Giannini, Bianchi, Sinigaglia, Di Munno, Fiore, Minisola, Rossini (CR2) 2009; 20
Sakai, Demay (CR130) 20
RM Francis (429_CR50) 1996; 6
P Li (429_CR83) 2004; 279
D Felsenberg (429_CR49) 2011; 11
O Aguilera (429_CR3) 2007; 28
RU Simpson (429_CR140) 2007; 103
AA Khan (429_CR70) 2009; 37
K Yudoh (429_CR170) 1999; 133
Y Morán-Auth (429_CR103) 2013; 136
Q Miao (429_CR99) 2013; 48
KJ Martin (429_CR93) 1998; 9
DM Albert (429_CR7) 2004; 122
KW Colston (429_CR36) 1997; 76
HZ Ke (429_CR69) 2005; 20
CW Nemerovski (429_CR109) 2009; 29
KA Nibbelink (429_CR110) 2007; 103
X Wang (429_CR160) 2016; 178
TM Beer (429_CR11) 2004; 3
PC van de Kerkhof (429_CR156) 2002; 146
S Adami (429_CR2) 2009; 20
J Cheng (429_CR25) 2014; 55
T Fujita (429_CR52) 2007; 25
F Duranton (429_CR44) 2013; 37
L Drocourt (429_CR42) 2002; 277
DJ Mantell (429_CR91) 2000; 87
M Guzey (429_CR58) 2002; 1
RJ Grostern (429_CR56) 2002; 120
R Okamoto (429_CR112) 2012; 130
B Prietl (429_CR123) 2013; 5
SH Zhuang (429_CR173) 1998; 139
TD Bell (429_CR12) 2010; 111
S Kawa (429_CR68) 1996; 110
JJ Eloranta (429_CR47) 2012; 82
HJ Maeng (429_CR88) 2012; 46
AJ Brown (429_CR20) 1989; 84
EC Chow (429_CR31) 2013; 34
E van Etten (429_CR153) 2005; 97
YC Kim (429_CR71) 2014; 103
M Hirata (429_CR62) 2002; 17
GG Schwartz (429_CR134) 1997; 6
MF Holick (429_CR64) 1996; 1
P Di Filippo (429_CR41) 2015; 166
KJ Martin (429_CR94) 1998; 32
EC Chow (429_CR28) 2010; 31
V Bhatia (429_CR15) 2009; 8
AJ Brown (429_CR21) 1990; 29
K Hara (429_CR59) 2001; 21
KG Barrett (429_CR10) 2016; 44
S Majewski (429_CR89) 1996; 1
P Milde (429_CR100) 1991; 97
QM Wang (429_CR158) 1996; 56
Y Ma (429_CR85) 2010; 116
J Lemire (429_CR80) 2000; 59
MF Holick (429_CR63) 2004; 79
HJ Maeng (429_CR87) 2011; 32
TF McGuire (429_CR97) 2001; 276
N Kubodera (429_CR75) 2003; 88
HP Quach (429_CR124) 2018; 39
C Zierold (429_CR174) 2006; 69
SG Rostand (429_CR129) 1999; 56
DD Bikle (429_CR17) 2004; 122
K Nakagawa (429_CR105) 2005; 26
NK Shevde (429_CR139) 2002; 99
I Echchgadda (429_CR45) 2004; 65
TK Wöbke (429_CR165) 2014; 5
AN Ananthakrishnan (429_CR8) 2012; 142
HG Pálmer (429_CR113) 2003; 63
C Daniel (429_CR38) 2008; 324
V Martinelli (429_CR95) 2014; 20
S Goto (429_CR55) 2008; 1
A Rahman (429_CR125) 2007; 103
J Welsh (429_CR164) 2003; 133
K Kragballe (429_CR73) 1988; 119
S Peleg (429_CR116) 2002; 143
C Pepper (429_CR118) 2003; 101
HS Cross (429_CR37) 1991; 179
HJ Lee (429_CR78) 2010; 121
N Pendás-Franco (429_CR117) 2008; 27
CJ Narvaez (429_CR106) 2014; 5
W Seubwai (429_CR136) 2010; 116
EC Chow (429_CR27) 2009; 30
MC Monier-Faugere (429_CR102) 1999; 55
Y Xu (429_CR167) 2006; 28
V Sung (429_CR145) 2000; 164
MJ Campbell (429_CR22) 1997; 89
F Jiang (429_CR66) 2003; 278
EA Rondini (429_CR128) 2014; 42
PC van de Kerkhof (429_CR155) 1989; 120
KC Chiang (429_CR26) 2013; 15
Y Miyachi (429_CR101) 2002; 12
RE Weishaar (429_CR162) 1987; 79
EC Chow (429_CR29) 2011; 337
A Abou-Raya (429_CR1) 2013; 40
P Schmiedlin-Ren (429_CR132) 1997; 51
KW Colston (429_CR35) 1992; 44
M Yasuda (429_CR168) 2003; 41
GG Schwartz (429_CR135) 2008; 7
X Guo (429_CR57) 2012; 27
SA Shedeed (429_CR138) 2012; 33
A Torres (429_CR150) 2004; 65
M Hayashi (429_CR61) 2004; 19
X Chen (429_CR24) 2006; 69
J Reichrath (429_CR126) 2007; 16
RH Getzenberg (429_CR53) 1997; 50
PD Thompson (429_CR148) 2002; 299
Y Ma (429_CR86) 2013; 12
Y Zhang (429_CR171) 2006; 5
W Xiang (429_CR166) 2005; 288
BP Kota (429_CR72) 2012; 26
C Pierrot-Deseilligny (429_CR120) 2012; 5
Y Shapira (429_CR137) 2010; 6
IS Yoon (429_CR169) 2015; 38
H Zhang (429_CR172) 2013; 3
Y Nishizawa (429_CR111) 1991; 90
NS Bricker (429_CR19) 1972; 286
A Muto (429_CR104) 1999; 93
A Bener (429_CR13) 2012; 157
EC Chow (429_CR30) 2011; 100
DD Bikle (429_CR16) 2014; 21
E Slatopolsky (429_CR141) 1995; 26
Y Imanishi (429_CR65) 1999; 70
F Li (429_CR84) 2011; 81
E Slatopolsky (429_CR142) 2003; 63
K Colston (429_CR34) 1981; 108
B Lehmann (429_CR79) 2004; 4
J Åivo (429_CR4) 2015; 280
S Pilz (429_CR122) 2008; 93
C Carlberg (429_CR23) 1995; 231
HF DeLuca (429_CR39) 2008; 66
TC McCarthy (429_CR96) 2005; 280
JN Barker (429_CR9) 1999; 141
MB Meyer (429_CR98) 2012; 26
MR Park (429_CR115) 2012; 27
F Richy (429_CR127) 2004; 15
T Soleymani (429_CR144) 2015; 54
A Pèrez (429_CR119) 1996; 134
WB Bollag (429_CR18) 2007; 127
I Chung (429_CR32) 2009; 69
MR Walters (429_CR157) 1987; 262
JY So (429_CR143) 2011; 79
C Durakovic (429_CR43) 2001; 144
T Kumagai (429_CR76) 2003; 95
K Kragballe (429_CR74) 1991; 337
Z Ghous (429_CR54) 2008; 28
TJ Wang (429_CR159) 2008; 117
Y Sakai (429_CR130) 2000; 141
T Akizawa (429_CR6) 2004; 8
JA Sunyecz (429_CR146) 2008; 4
M Makishima (429_CR90) 2002; 17
E Papadimitropoulos (429_CR114) 2002; 23
T Akizawa (429_CR5) 2002; 17
J Fan (429_CR48) 2009; 330
I Katayama (429_CR67) 2002; 12
T Naveh-Many (429_CR107) 1993; 133
RE Weishaar (429_CR163) 1990; 258
S Pilz (429_CR121) 2008; 39
AE El-Agroudy (429_CR46) 2003; 14
P Naveilhan (429_CR108) 1994; 37
PR van Ginkel (429_CR154) 2007; 85
C Leyssens (429_CR82) 2014; 5
RE Weishaar (429_CR161) 1987; 253
A Marchwicka (429_CR92) 2014; 4
T Fujioka (429_CR51) 1998; 160
L Hargrove (429_CR60) 2014; 2
AD Levin (429_CR81) 2011; 56
S Tamura (429_CR147) 2005; 9
KE Thummel (429_CR149) 2001; 60
DL Trump (429_CR152) 2010; 16
RJ Bernardi (429_CR14) 2002; 143
JW Coburn (429_CR33) 2004; 43
HF DeLuca (429_CR40) 2011; 26
SS Schleithoff (429_CR131) 2006; 83
JB Schwartz (429_CR133) 2009; 85
L Trémezaygues (429_CR151) 2011; 3
MS LeBoff (429_CR77) 1999; 251
References_xml – volume: 279
  start-page: 25260
  year: 2004
  end-page: 25267
  ident: CR83
  article-title: p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase
  publication-title: J Biol Chem
– volume: 27
  start-page: 1037
  year: 2012
  end-page: 1043
  ident: CR115
  article-title: Suppressive effect of 19-nor-1α-25-dihydroxyvitamin D2 on gastric cancer cells and peritoneal metastasis model
  publication-title: J Korean Med Sci
– volume: 66
  start-page: S73
  year: 2008
  end-page: S87
  ident: CR39
  article-title: Evolution of our understanding of vitamin D
  publication-title: Nutr Rev
– volume: 141
  start-page: 2043
  year: 2000
  end-page: 2049
  ident: CR130
  article-title: Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice
  publication-title: Endocrinology
– volume: 28
  start-page: 1877
  year: 2007
  end-page: 1884
  ident: CR3
  article-title: The Wnt antagonist DICKKOPF-1 gene is induced by 1α,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells
  publication-title: Carcinogenesis
– volume: 11
  start-page: 34
  year: 2011
  end-page: 45
  ident: CR49
  article-title: Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass
  publication-title: J Musculoskelet Neuronal Interact
– volume: 142
  start-page: 482
  year: 2012
  end-page: 489
  ident: CR8
  article-title: Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease
  publication-title: Gastroenterology
– volume: 120
  start-page: 607
  year: 2002
  end-page: 612
  ident: CR56
  article-title: Toxicity and dose-response studies of 1α-hydroxyvitamin D2 in a retinoblastoma xenograft model
  publication-title: Arch Ophthalmol
– volume: 99
  start-page: 13487
  year: 2002
  end-page: 13491
  ident: CR139
  article-title: A potent analog of 1α,25-dihydroxyvitamin D3 selectively induces bone formation
  publication-title: Proc Natl Acad Sci USA
– volume: 4
  start-page: 827
  year: 2008
  end-page: 836
  ident: CR146
  article-title: The use of calcium and vitamin D in the management of osteoporosis
  publication-title: Ther Clin Risk Manag
– volume: 9
  start-page: 238
  year: 2005
  end-page: 243
  ident: CR147
  article-title: Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients
  publication-title: Clin Exp Nephrol
– volume: 280
  start-page: 12
  year: 2015
  end-page: 15
  ident: CR4
  article-title: Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta
  publication-title: J Neuroimmunol
– volume: 31
  start-page: 91
  year: 2010
  end-page: 108
  ident: CR28
  article-title: Effects of 1α,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney .
  publication-title: Biopharm Drug Dispos
– volume: 20
  start-page: 147
  year: 2014
  end-page: 155
  ident: CR95
  article-title: Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes
  publication-title: Mult Scler
– volume: 20
  start-page: 239
  year: 2009
  end-page: 244
  ident: CR2
  article-title: Vitamin D status and response to treatment in post-menopausal osteoporosis
  publication-title: Osteoporos Int
– volume: 231
  start-page: 517
  issue: 3
  year: 1995
  end-page: 527
  ident: CR23
  article-title: Mechanisms of nuclear signalling by vitamin D3. Interplay with retinoid and thyroid hormone signalling
  publication-title: Eur J Biochem
– volume: 262
  start-page: 2536
  year: 1987
  end-page: 2541
  ident: CR157
  article-title: 1,25-Dihydroxyvitamin D3 stimulates 45Ca2+ uptake by cultured adult rat ventricular cardiac muscle cells
  publication-title: J Biol Chem
– volume: 97
  start-page: 93
  year: 2005
  end-page: 101
  ident: CR153
  article-title: Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts
  publication-title: J Steroid Biochem Mol Biol
– volume: 8
  start-page: 1787
  year: 2009
  end-page: 1798
  ident: CR15
  article-title: EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells
  publication-title: Mol Cancer Ther
– volume: 16
  start-page: 618
  year: 2007
  end-page: 625
  ident: CR126
  article-title: Vitamin D and the skin: an ancient friend, revisited
  publication-title: Exp Dermatol
– volume: 48
  start-page: 351
  year: 2013
  end-page: 359
  ident: CR99
  article-title: Inhibitory effect of 1α,25-dihydroxyvitamin D on excretion of JBP485 via organic anion transporters in rats
  publication-title: Eur J Pharm Sci
– volume: 6
  start-page: 468
  year: 2010
  end-page: 476
  ident: CR137
  article-title: Geoepidemiology of autoimmune rheumatic diseases
  publication-title: Nat Rev Rheumatol
– volume: 70
  start-page: 243
  year: 1999
  end-page: 248
  ident: CR65
  article-title: Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells
  publication-title: J Steroid Biochem Mol Biol
– volume: 26
  start-page: 538
  year: 2011
  end-page: 545
  ident: CR40
  article-title: The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial
  publication-title: J Bone Miner Res
– volume: 120
  start-page: 661
  year: 1989
  end-page: 664
  ident: CR155
  article-title: A double-blind study of topical 1 α,25-dihydroxyvitamin D3 in psoriasis
  publication-title: Br J Dermatol
– volume: 37
  start-page: 115
  issue: 2
  year: 2009
  end-page: 125
  ident: CR70
  article-title: Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver
  publication-title: Eur J Pharm Sci
– volume: 12
  start-page: 553
  year: 2002
  end-page: 557
  ident: CR67
  article-title: High-concentration (20mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids
  publication-title: Eur J Dermatol
– volume: 3
  start-page: 237
  year: 2013
  end-page: 240
  ident: CR172
  article-title: Mechanisms underlying effects of 1,25-Dihydroxyvitamin D3 on the Th17 cells
  publication-title: Eur J Microbiol Immunol (Bp)
– volume: 110
  start-page: 1605
  year: 1996
  end-page: 1613
  ident: CR68
  article-title: Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines
  publication-title: Gastroenterology
– volume: 17
  start-page: 41
  issue: suppl 10
  year: 2002
  end-page: 45
  ident: CR62
  article-title: A comparison between 1,25-dihydroxy-22-oxavitamin D3 and 1,25-dihydroxyvitamin D3 regarding suppression of parathyroid hormone and calcemic action
  publication-title: Nephrol Dial Transplant
– volume: 134
  start-page: 238
  year: 1996
  end-page: 246
  ident: CR119
  article-title: Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis
  publication-title: Br J Dermatol
– volume: 26
  start-page: 37
  year: 2012
  end-page: 51
  ident: CR98
  article-title: VDR/RXR and TCF4/beta-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression
  publication-title: Mol Endocrinol
– volume: 32
  start-page: S61
  year: 1998
  end-page: S66
  ident: CR94
  article-title: Therapy of secondary hyperparathyroidism with 19-nor-1a,25-dihydroxyvitamin D2
  publication-title: Am J Kidney Dis
– volume: 63
  start-page: 2020
  year: 2003
  end-page: 2027
  ident: CR142
  article-title: Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia
  publication-title: Kidney Int
– volume: 8
  start-page: 480
  year: 2004
  end-page: 491
  ident: CR6
  article-title: Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism
  publication-title: Ther Apher Dial
– volume: 251
  start-page: 1505
  year: 1999
  end-page: 1511
  ident: CR77
  article-title: Occult vitamin D deficiency in postmenopausal US women with acute hip fracture
  publication-title: JAMA
– volume: 166
  start-page: 91
  year: 2015
  end-page: 96
  ident: CR41
  article-title: Vitamin D supplementation modulates the immune system and improves atopic dermatitis in children
  publication-title: Int Arch Allergy Immunol
– volume: 46
  start-page: 149
  year: 2012
  end-page: 166
  ident: CR88
  article-title: Effects of 1α,25-dihydroxyvitamin D3 on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells
  publication-title: Eur J Pharm Sci
– volume: 133
  start-page: 2425S
  year: 2003
  end-page: 2433S
  ident: CR164
  article-title: Vitamin D-3 receptor as a target for breast cancer prevention
  publication-title: J Nutr
– volume: 28
  start-page: 385
  year: 2006
  end-page: 392
  ident: CR167
  article-title: Selective induction of intestinal CYP3A23 by 1α,25-dihydroxyvitamin D3 in rats
  publication-title: Biochem Pharmacol
– volume: 87
  start-page: 214
  year: 2000
  end-page: 220
  ident: CR91
  article-title: 1 α,25-dihydroxyvitamin D(3) inhibits angiogenesis and
  publication-title: Circ Res
– volume: 5
  start-page: 447
  year: 2006
  end-page: 451
  ident: CR171
  article-title: AKT pathway is activated by 1, 25-dihydroxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells
  publication-title: Cell Cycle
– volume: 1
  start-page: 1
  year: 1996
  end-page: 9
  ident: CR64
  article-title: Clinical uses for calciotropic hormones 1,25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective
  publication-title: J Investig Dermatol Symp Proc
– volume: 117
  start-page: 503
  year: 2008
  end-page: 511
  ident: CR159
  article-title: Vitamin D deficiency and risk of cardiovascular disease
  publication-title: Circulation
– volume: 178
  start-page: 54
  year: 2016
  end-page: 62
  ident: CR160
  article-title: 1-A, 25-dihydroxyvitamin D3 alters the pharmacokinetics of mycophenolic acid in renal transplant recipients by regulating two extrahepatic UDP-glucuronosyltransferases 1A8 and 1A10
  publication-title: Transl Res
– volume: 15
  start-page: 1316
  year: 2013
  end-page: 1325
  ident: CR26
  article-title: Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells and
  publication-title: Cell Cycle
– volume: 51
  start-page: 741
  issue: 5
  year: 1997
  end-page: 754
  ident: CR132
  article-title: Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1α,25-dihydroxyvitamin D3
  publication-title: Mol Pharmacol
– volume: 44
  start-page: 693
  year: 1992
  end-page: 702
  ident: CR35
  article-title: Effects of synthetic vitamin D analogues on breast cancer cell proliferation and
  publication-title: Biochem Pharmacol
– volume: 1
  start-page: iii2
  issue: Suppl 3
  year: 2008
  end-page: iii8
  ident: CR55
  article-title: Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention
  publication-title: NDT Plus
– volume: 81
  start-page: 469
  year: 2011
  end-page: 475
  ident: CR84
  article-title: Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma
  publication-title: Respiration
– volume: 37
  start-page: 239
  year: 2013
  end-page: 248
  ident: CR44
  article-title: Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis
  publication-title: Am J Nephrol
– volume: 6
  start-page: 284
  year: 1996
  end-page: 290
  ident: CR50
  article-title: A comparison of the effects of alfacalcidol treatment and vitamin D2 supplementation on calcium absorption in elderly women with vertebral fractures
  publication-title: Osteoporos Int
– volume: 127
  start-page: 748
  year: 2007
  end-page: 750
  ident: CR18
  article-title: Differentiation of human keratinocytes requires the Vitamin D receptor and its coactivators
  publication-title: J Invest Dermatol
– volume: 4
  start-page: 125
  year: 2014
  ident: CR92
  article-title: Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients’ variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs
  publication-title: Front Oncol
– volume: 299
  start-page: 730
  issue: 5
  year: 2002
  end-page: 738
  ident: CR148
  article-title: Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements
  publication-title: Biochem Biophys Res Commun
– volume: 38
  start-page: 1732
  year: 2015
  end-page: 1737
  ident: CR169
  article-title: Effects of 1α,25-Dihydroxyvitamin D3 on intestinal absorption and disposition of adefovir dipivoxil and its metabolite, adefovir, in Rats
  publication-title: Biol Pharm Bull
– volume: 4
  start-page: 11
  year: 2004
  end-page: 15
  ident: CR79
  article-title: Vitamin D and skin: new aspects for dermatology
  publication-title: Exp Dermatol 13 Suppl
– volume: 15
  start-page: 301
  year: 2004
  end-page: 310
  ident: CR127
  article-title: Efficacy of αcalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate
  publication-title: Osteoporos Int
– volume: 1
  start-page: 667
  year: 2002
  end-page: 677
  ident: CR58
  article-title: Apoptosis induction by 1α,25-dihydroxyvitamin D3 in prostate cancer
  publication-title: Mol Cancer Ther
– volume: 26
  start-page: 429
  year: 2005
  end-page: 440
  ident: CR105
  article-title: 1 α,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer
  publication-title: Carcinogenesis
– volume: 130
  start-page: 2464
  year: 2012
  end-page: 2473
  ident: CR112
  article-title: Inecalcitol, an analog of 1α,25(OH)(2) D(3), induces growth arrest of androgen-dependent prostate cancer cells
  publication-title: Int J Cancer
– volume: 100
  start-page: 1594
  year: 2011
  end-page: 1604
  ident: CR30
  article-title: Comparative effects of doxercalciferol (1α-hydroxyvitamin D ) versus calcitriol (1α,25-dihydroxyvitamin D ) on the expression of transporters and enzymes in the rat
  publication-title: J Pharm Sci
– volume: 79
  start-page: 1706
  year: 1987
  end-page: 1712
  ident: CR162
  article-title: Vitamin D3 and cardiovascular function in rats
  publication-title: J Clin Invest
– volume: 29
  start-page: S22
  issue: Suppl. 29
  year: 1990
  end-page: S27
  ident: CR21
  article-title: New active analogues of vitamin D with low calcemic activity
  publication-title: Kidney Int
– volume: 39
  start-page: 2611
  year: 2008
  end-page: 2613
  ident: CR121
  article-title: Low vitamin d levels predict stroke in patients referred to coronary angiography
  publication-title: Stroke
– volume: 5
  start-page: 2502
  year: 2013
  end-page: 2521
  ident: CR123
  article-title: Vitamin D and Immune Function
  publication-title: Nutrients
– volume: 44
  start-page: 1431
  issue: 8
  year: 2016
  end-page: 1434
  ident: CR10
  article-title: Transcriptional regulation of cytosolic sulfotransferase 1C2 by vitamin D receptor in LS180 human colorectal adenocarcinoma cells
  publication-title: Drug Metab Dispos
– volume: 160
  start-page: 247
  year: 1998
  end-page: 251
  ident: CR51
  article-title: Inhibition of tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinoma
  publication-title: J Urol
– volume: 141
  start-page: 274
  year: 1999
  end-page: 278
  ident: CR9
  article-title: Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator
  publication-title: Br J Dermatol
– volume: 79
  start-page: 362
  year: 2004
  end-page: 371
  ident: CR63
  article-title: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis
  publication-title: Am J Clin Nutr
– volume: 79
  start-page: 360
  year: 2011
  end-page: 367
  ident: CR143
  article-title: A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer
  publication-title: Mol Pharmacol
– volume: 41
  start-page: S108
  year: 2003
  end-page: S111
  ident: CR168
  article-title: Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients
  publication-title: Am J Kidney Dis
– volume: 32
  start-page: 112
  year: 2011
  end-page: 125
  ident: CR87
  article-title: 1α,25-dihydroxyvitamin D3 on intestinal transporter function: studies with the rat everted intestinal sac
  publication-title: Biopharm Drug Dispos
– volume: 42
  start-page: 361
  issue: 3
  year: 2014
  end-page: 368
  ident: CR128
  article-title: Regulation of human cytosolic sulfotransferases 1C2 and 1C3 by nuclear signaling pathways in LS180 colorectal adenocarcinoma cells
  publication-title: Drug Metab Dispos
– volume: 76
  start-page: 1017
  year: 1997
  end-page: 1020
  ident: CR36
  article-title: Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells and
  publication-title: Br J Cancer
– volume: 84
  start-page: 728
  year: 1989
  end-page: 732
  ident: CR20
  article-title: The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion
  publication-title: J Clin Invest
– volume: 82
  start-page: 37
  year: 2012
  end-page: 46
  ident: CR47
  article-title: The SLCO1A2 gene, encoding human organic anion-transporting polypeptide 1A2, is transactivated by the vitamin D receptor
  publication-title: Mol Pharmacol
– volume: 157
  start-page: 168
  year: 2012
  end-page: 175
  ident: CR13
  article-title: Vitamin D deficiency as a strong predictor of asthma in children
  publication-title: Int Arch Allergy Immunol
– volume: 27
  start-page: 232
  year: 2012
  end-page: 241
  ident: CR57
  article-title: Peptide cotransporter 1 in intestine and organic anion transporters in kidney are targets of interaction between JBP485 and lisinopril in rats
  publication-title: Drug Metab Pharmacokinet
– volume: 122
  start-page: 984
  year: 2004
  end-page: 992
  ident: CR17
  article-title: 25-Hydroxyvitamin D 1 α-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis
  publication-title: J Invest Dermatol
– volume: 258
  start-page: E134
  year: 1990
  end-page: E142
  ident: CR163
  article-title: Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties
  publication-title: Am J Physiol
– volume: 179
  start-page: 57
  year: 1991
  end-page: 62
  ident: CR37
  article-title: Antiproliferative effect of 1,25-dihydroxyvitamin D3 and its analogs on human colon adenocarcinoma cells (CaCo-2): influence of extracellular calcium
  publication-title: Biochem Biophys Res Commun
– volume: 143
  start-page: 1625
  year: 2002
  end-page: 1636
  ident: CR116
  article-title: Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats
  publication-title: Endocrinology
– volume: 116
  start-page: 5535
  year: 2010
  end-page: 5543
  ident: CR136
  article-title: 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma
  publication-title: Cancer
– volume: 56
  start-page: 830
  year: 2011
  end-page: 836
  ident: CR81
  article-title: Vitamin D deficiency in children with inflammatory bowel disease
  publication-title: Dig Dis Sci
– volume: 103
  start-page: 533
  year: 2007
  end-page: 537
  ident: CR110
  article-title: 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte
  publication-title: J Steroid Biochem Mol Biol
– volume: 33
  start-page: 713
  year: 2012
  end-page: 719
  ident: CR138
  article-title: Vitamin D supplementation in infants with chronic congestive heart failure
  publication-title: Pediatr Cardiol
– volume: 144
  start-page: 500
  year: 2001
  end-page: 506
  ident: CR43
  article-title: Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study
  publication-title: Br J Dermatol
– volume: 337
  start-page: 193
  year: 1991
  end-page: 196
  ident: CR74
  article-title: Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
  publication-title: Lancet
– volume: 324
  start-page: 23
  year: 2008
  end-page: 33
  ident: CR38
  article-title: Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile
  publication-title: Pharmacol Exp Ther
– volume: 95
  start-page: 896
  year: 2003
  end-page: 905
  ident: CR76
  article-title: Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells
  publication-title: J Natl Cancer Inst
– volume: 55
  start-page: 821
  year: 1999
  end-page: 832
  ident: CR102
  article-title: 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure
  publication-title: Kidney Int
– volume: 12
  start-page: 463
  year: 2002
  end-page: 468
  ident: CR101
  article-title: Long-term safety and efficacy of high-concentration (20microg/g) tacalcitol ointment in psoriasis vulgaris
  publication-title: Eur J Dermatol
– volume: 59
  start-page: 24
  issue: Suppl 1
  year: 2000
  end-page: 27
  ident: CR80
  article-title: 1,25-Dihydroxyvitamin D3-a hormone with immunomodulatory properties
  publication-title: Z Rheumatol
– volume: 12
  start-page: 743
  year: 2013
  end-page: 752
  ident: CR86
  article-title: Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system
  publication-title: Cell Cycle
– volume: 1
  start-page: 97
  year: 1996
  end-page: 101
  ident: CR89
  article-title: Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis
  publication-title: J Investig Dermatol Symp Proc
– volume: 60
  start-page: 1399
  year: 2001
  end-page: 1406
  ident: CR149
  article-title: Transcriptional control of intestinal cytochrome P-4503A by 1α,25-dihydroxy vitamin D3
  publication-title: Mol Pharmacol
– volume: 89
  start-page: 182
  year: 1997
  end-page: 185
  ident: CR22
  article-title: Toward therapeutic intervention of cancer by vitamin D compounds
  publication-title: J Natl Cancer Inst
– volume: 276
  start-page: 26365
  year: 2001
  end-page: 26373
  ident: CR97
  article-title: Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1
  publication-title: J Biol Chem
– volume: 43
  start-page: 877
  issue: 5
  year: 2004
  end-page: 890
  ident: CR33
  article-title: Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4
  publication-title: Am J Kidney Dis
– volume: 69
  start-page: 1913
  year: 2006
  end-page: 1923
  ident: CR24
  article-title: Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1α,25-dihydroxyvitamin D3 via the vitamin D receptor
  publication-title: Mol Pharmacol
– volume: 103
  start-page: 3793
  year: 2014
  end-page: 3805
  ident: CR71
  article-title: Effects of 1α,25-dihydroxyvitamin D3, the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat
  publication-title: J Pharm Sci
– volume: 56
  start-page: 264
  year: 1996
  end-page: 267
  ident: CR158
  article-title: Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells
  publication-title: Cancer Res
– volume: 17
  start-page: 1313
  year: 2002
  end-page: 1316
  ident: CR90
  article-title: Vitamin D receptor as an intestinal bile acid sensor
  publication-title: Science
– volume: 88
  start-page: 286
  year: 2003
  end-page: 289
  ident: CR75
  article-title: A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients
  publication-title: J Cell Biochem
– volume: 40
  start-page: 265
  year: 2013
  end-page: 272
  ident: CR1
  article-title: The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial
  publication-title: J Rheumatol
– volume: 26
  start-page: 543
  year: 2012
  end-page: 548
  ident: CR72
  article-title: Effect of vitamin D3 supplementation on the pharmacokinetics of digoxin—a pilot study
  publication-title: Fundam Clin Pharmacol
– volume: 26
  start-page: 852
  year: 1995
  end-page: 860
  ident: CR141
  article-title: A new analog of calcitriol, 19-nor-1,25-(OH)2 D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia
  publication-title: Am J Kidney Dis
– volume: 111
  start-page: 7
  year: 2010
  end-page: 13
  ident: CR12
  article-title: The biology and pathology of vitamin D control in bone
  publication-title: J Cell Biochem
– volume: 136
  start-page: 83
  year: 2013
  end-page: 85
  ident: CR103
  article-title: Vitamin D status and gene transcription in immune cells
  publication-title: J Steroid Biochem Mol Biol
– volume: 5
  start-page: 122
  year: 2014
  ident: CR82
  article-title: The future of vitamin D analogs
  publication-title: Front Physiol
– volume: 277
  start-page: 25125
  issue: 28
  year: 2002
  end-page: 25132
  ident: CR42
  article-title: Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes
  publication-title: J Biol Chem
– volume: 37
  start-page: 271
  year: 1994
  end-page: 277
  ident: CR108
  article-title: Induction of glioma cell death by 1,25(OH)2 vitamin D3: towards an endocrine therapy of brain tumors?
  publication-title: J Neurosci Res
– volume: 103
  start-page: 521
  year: 2007
  end-page: 524
  ident: CR140
  article-title: Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse
  publication-title: J Steroid Biochem Mol Biol
– volume: 3
  start-page: 180
  year: 2011
  end-page: 186
  ident: CR151
  article-title: Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going?
  publication-title: Dermatoendocrinol
– volume: 63
  start-page: 7799
  year: 2003
  end-page: 7806
  ident: CR113
  article-title: Genetic signatures of differentiation induced by 1α,25-dihydroxyvitamin D3 in human colon cancer cells
  publication-title: Cancer Res
– volume: 253
  start-page: E675
  year: 1987
  end-page: E683
  ident: CR161
  article-title: Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects
  publication-title: Am J Physiol
– volume: 21
  start-page: 321
  year: 2001
  end-page: 324
  ident: CR59
  article-title: Oral administration of 1α hydroxyvitamin D3 inhibits tumor growth and metastasis of a murine osteosarcoma model
  publication-title: Anticancer Res
– volume: 5
  start-page: 187
  year: 2012
  end-page: 198
  ident: CR120
  article-title: Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation
  publication-title: Ther Adv Neurol Disord
– volume: 30
  start-page: 457
  year: 2009
  end-page: 475
  ident: CR27
  article-title: 1α,25-Dihydroxyvitamin D(3) triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver
  publication-title: Biopharm Drug Dispos
– volume: 3
  start-page: 373
  year: 2004
  end-page: 381
  ident: CR11
  article-title: Calcitriol in cancer treatment: from the lab to the clinic
  publication-title: Mol Cancer Ther
– volume: 288
  start-page: E125
  year: 2005
  end-page: E132
  ident: CR166
  article-title: Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems
  publication-title: Am J Physiol Endocrinol Metab
– volume: 83
  start-page: 754
  year: 2006
  end-page: 759
  ident: CR131
  article-title: Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial
  publication-title: Am J Clin Nutr
– volume: 93
  start-page: 2225
  year: 1999
  end-page: 2233
  ident: CR104
  article-title: 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1)
  publication-title: Blood
– volume: 69
  start-page: 1740
  year: 2006
  end-page: 1747
  ident: CR174
  article-title: 19nor-1,25-dihydroxyvitamin D2 specifically induces CYP3A9 in rat intestine more strongly than 1,25-dihydroxyvitamin D3 and
  publication-title: Mol Pharmacol
– volume: 56
  start-page: 383
  year: 1999
  end-page: 392
  ident: CR129
  article-title: Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure
  publication-title: Kidney Int
– volume: 19
  start-page: 2067
  year: 2004
  end-page: 2073
  ident: CR61
  article-title: Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial
  publication-title: Nephrol Dial Transplant
– volume: 85
  start-page: 255
  year: 2007
  end-page: 262
  ident: CR154
  article-title: 1 α-Hydroxyvitamin D2 inhibits growth of human neuroblastoma
  publication-title: J Neurooncol
– volume: 2
  start-page: 9
  year: 2014
  ident: CR60
  article-title: Vitamin D and GI cancers: shedding some light on dark diseases
  publication-title: Ann Transl Med
– volume: 133
  start-page: 2724
  year: 1993
  end-page: 2728
  ident: CR107
  article-title: Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression
  publication-title: Endocrinology
– volume: 17
  start-page: 28
  issue: Suppl. 10
  year: 2002
  end-page: 36
  ident: CR5
  article-title: Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study
  publication-title: Nephrol Dial Transplant
– volume: 103
  start-page: 416
  year: 2007
  end-page: 419
  ident: CR125
  article-title: Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice
  publication-title: J Steroid Biochem Mol Biol
– volume: 116
  start-page: 3294
  year: 2010
  end-page: 3303
  ident: CR85
  article-title: 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models
  publication-title: Cancer
– volume: 139
  start-page: 1197
  year: 1998
  end-page: 1207
  ident: CR173
  article-title: Antiproliferative effect of 1α,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation
  publication-title: Endocrinology
– volume: 286
  start-page: 1093
  year: 1972
  end-page: 1099
  ident: CR19
  article-title: On the pathogenesis of the uremic state. An exposition of the ‘trade-off hypothesis’
  publication-title: N Engl J Med
– volume: 28
  start-page: 3757
  year: 2008
  end-page: 3761
  ident: CR54
  article-title: Inhibition of hepatocellular cancer by EB1089: and study
  publication-title: Anticancer Res
– volume: 5
  start-page: 213
  year: 2014
  ident: CR106
  article-title: The impact of vitamin D in breast cancer: genomics, pathways, metabolism
  publication-title: Front Physiol
– volume: 39
  start-page: 99
  year: 2018
  end-page: 115
  ident: CR124
  article-title: Alterations in gene expression in vitamin D-deficiency: Down-regulation of liver Cyp7a1 and renal Oat3 in mice
  publication-title: Biopharm Drug Dispos
– volume: 6
  start-page: 727
  year: 1997
  end-page: 732
  ident: CR134
  article-title: 1α,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 65
  start-page: 720
  issue: 3
  year: 2004
  end-page: 729
  ident: CR45
  article-title: Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor
  publication-title: Mol Pharmacol
– volume: 280
  start-page: 23232
  issue: 24
  year: 2005
  end-page: 23242
  ident: CR96
  article-title: Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids
  publication-title: J Biol Chem
– volume: 97
  start-page: 230
  year: 1991
  end-page: 239
  ident: CR100
  article-title: Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin
  publication-title: J Invest Dermatol
– volume: 25
  start-page: 130
  year: 2007
  end-page: 137
  ident: CR52
  article-title: Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol
  publication-title: J Bone Miner Metab
– volume: 133
  start-page: 120
  year: 1999
  end-page: 128
  ident: CR170
  article-title: 1α,25-dihydroxyvitamin D3 inhibits invasiveness through the extracellular matrix and pulmonary metastasis of B16 mouse melanoma
  publication-title: J Lab Clin Med
– volume: 108
  start-page: 1083
  year: 1981
  end-page: 1086
  ident: CR34
  article-title: 1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture
  publication-title: Endocrinology
– volume: 278
  start-page: 48030
  year: 2003
  end-page: 48040
  ident: CR66
  article-title: G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer
  publication-title: J Biol Chem
– volume: 93
  start-page: 3927
  year: 2008
  end-page: 3935
  ident: CR122
  article-title: Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography
  publication-title: J Clin Endocrinol Metab
– volume: 23
  start-page: 560
  year: 2002
  end-page: 569
  ident: CR114
  article-title: Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women
  publication-title: Endocr Rev
– volume: 21
  start-page: 319
  year: 2014
  end-page: 329
  ident: CR16
  article-title: Vitamin D metabolism, mechanism of action, and clinical applications
  publication-title: Chem Biol
– volume: 69
  start-page: 967
  year: 2009
  end-page: 975
  ident: CR32
  article-title: Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis
  publication-title: Cancer Res
– volume: 90
  start-page: 196
  year: 1991
  end-page: 203
  ident: CR111
  article-title: Clinical trial of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 in uremic patients on hemodialysis: preliminary report
  publication-title: Contrib Nephrol
– volume: 14
  start-page: 2975
  year: 2003
  end-page: 2979
  ident: CR46
  article-title: Preventing bone loss in renal transplant recipients with vitamin D
  publication-title: J Am Soc Nephrol
– volume: 50
  start-page: 999
  year: 1997
  end-page: 1006
  ident: CR53
  article-title: Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system
  publication-title: Urology
– volume: 101
  start-page: 2454
  year: 2003
  end-page: 2460
  ident: CR118
  article-title: The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells
  publication-title: Blood
– volume: 65
  start-page: 705
  year: 2004
  end-page: 712
  ident: CR150
  article-title: Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation
  publication-title: Kidney Int
– volume: 122
  start-page: 1357
  year: 2004
  end-page: 1362
  ident: CR7
  article-title: Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models
  publication-title: Arch Ophthalmol
– volume: 20
  start-page: 1742
  year: 2005
  end-page: 1755
  ident: CR69
  article-title: A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia
  publication-title: J Bone Miner Res
– volume: 119
  start-page: 223
  year: 1988
  end-page: 230
  ident: CR73
  article-title: Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study
  publication-title: Br J Dermatol
– volume: 54
  start-page: 383
  year: 2015
  end-page: 392
  ident: CR144
  article-title: The role of vitamin D in psoriasis: a review
  publication-title: Int J Dermatol
– volume: 16
  start-page: 1
  year: 2010
  end-page: 9
  ident: CR152
  article-title: Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy
  publication-title: Cancer J
– volume: 9
  start-page: 1427
  year: 1998
  end-page: 1432
  ident: CR93
  article-title: 19-Nor-1a,25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis
  publication-title: J Am Soc Nephrol
– volume: 330
  start-page: 389
  year: 2009
  end-page: 402
  ident: CR48
  article-title: Up-regulation of transporters and enzymes by the vitamin D receptor ligands, 1α,25-dihydroxyvitamin D3 and vitamin D analogs, in the Caco-2 cell monolayer
  publication-title: J Pharmacol Exp Ther
– volume: 5
  start-page: 244
  year: 2014
  ident: CR165
  article-title: Vitamin D in inflammatory diseases
  publication-title: Front Physiol
– volume: 55
  start-page: 455
  issue: 3
  year: 2014
  end-page: 465
  ident: CR25
  article-title: Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice
  publication-title: J Lipid Res
– volume: 164
  start-page: 133
  year: 2000
  end-page: 143
  ident: CR145
  article-title: 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration
  publication-title: Mol Cell Endocrinol
– volume: 85
  start-page: 198
  issue: 2
  year: 2009
  end-page: 203
  ident: CR133
  article-title: Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence
  publication-title: Clin Pharmacol Ther
– volume: 27
  start-page: 4467
  year: 2008
  end-page: 4477
  ident: CR117
  article-title: DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1α,25-dihydroxyvitamin D3
  publication-title: Oncogene
– volume: 121
  start-page: 408
  year: 2010
  end-page: 412
  ident: CR78
  article-title: Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling
  publication-title: J Steroid Biochem Mol Biol
– volume: 34
  start-page: 402
  year: 2013
  end-page: 416
  ident: CR31
  article-title: Comparative effects of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(-/-) mice
  publication-title: Biopharm Drug Dispos
– volume: 7
  start-page: 430
  year: 2008
  end-page: 436
  ident: CR135
  article-title: 19-nor-1 α,25-dihydroxyvitamin D2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells and
  publication-title: Cancer Biol Ther
– volume: 146
  start-page: 414
  year: 2002
  end-page: 422
  ident: CR156
  article-title: Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis
  publication-title: Br J Dermatol
– volume: 337
  start-page: 846
  year: 2011
  end-page: 859
  ident: CR29
  article-title: 1A,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-/-) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice
  publication-title: J Pharmacol Exp Ther
– volume: 29
  start-page: 691
  year: 2009
  end-page: 708
  ident: CR109
  article-title: Vitamin D and cardiovascular disease
  publication-title: Pharmacotherapy
– volume: 143
  start-page: 2508
  year: 2002
  end-page: 2514
  ident: CR14
  article-title: Antiproliferative effects of 1α,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells
  publication-title: Endocrinology
– volume: 286
  start-page: 1093
  year: 1972
  ident: 429_CR19
  publication-title: N Engl J Med
  doi: 10.1056/NEJM197205182862009
– volume: 28
  start-page: 3757
  year: 2008
  ident: 429_CR54
  publication-title: Anticancer Res
– volume: 251
  start-page: 1505
  year: 1999
  ident: 429_CR77
  publication-title: JAMA
  doi: 10.1001/jama.281.16.1505
– volume: 81
  start-page: 469
  year: 2011
  ident: 429_CR84
  publication-title: Respiration
  doi: 10.1159/000322008
– volume: 23
  start-page: 560
  year: 2002
  ident: 429_CR114
  publication-title: Endocr Rev
  doi: 10.1210/er.2001-8002
– volume: 120
  start-page: 607
  year: 2002
  ident: 429_CR56
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.120.5.607
– volume: 143
  start-page: 2508
  year: 2002
  ident: 429_CR14
  publication-title: Endocrinology
  doi: 10.1210/endo.143.7.8887
– volume: 100
  start-page: 1594
  year: 2011
  ident: 429_CR30
  publication-title: J Pharm Sci
  doi: 10.1002/jps.22366
– volume: 299
  start-page: 730
  issue: 5
  year: 2002
  ident: 429_CR148
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/S0006-291X(02)02742-0
– volume: 27
  start-page: 232
  year: 2012
  ident: 429_CR57
  publication-title: Drug Metab Pharmacokinet
  doi: 10.2133/dmpk.DMPK-11-RG-089
– volume: 93
  start-page: 3927
  year: 2008
  ident: 429_CR122
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-0784
– volume: 4
  start-page: 125
  year: 2014
  ident: 429_CR92
  publication-title: Front Oncol
  doi: 10.3389/fonc.2014.00125
– volume: 108
  start-page: 1083
  year: 1981
  ident: 429_CR34
  publication-title: Endocrinology
  doi: 10.1210/endo-108-3-1083
– volume: 63
  start-page: 7799
  year: 2003
  ident: 429_CR113
  publication-title: Cancer Res
– volume: 34
  start-page: 402
  year: 2013
  ident: 429_CR31
  publication-title: Biopharm Drug Dispos
  doi: 10.1002/bdd.1856
– volume: 84
  start-page: 728
  year: 1989
  ident: 429_CR20
  publication-title: J Clin Invest
  doi: 10.1172/JCI114229
– volume: 11
  start-page: 34
  year: 2011
  ident: 429_CR49
  publication-title: J Musculoskelet Neuronal Interact
– volume: 99
  start-page: 13487
  year: 2002
  ident: 429_CR139
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.202471299
– volume: 26
  start-page: 538
  year: 2011
  ident: 429_CR40
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.256
– volume: 19
  start-page: 2067
  year: 2004
  ident: 429_CR61
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfh329
– volume: 12
  start-page: 743
  year: 2013
  ident: 429_CR86
  publication-title: Cell Cycle
  doi: 10.4161/cc.23846
– volume: 120
  start-page: 661
  year: 1989
  ident: 429_CR155
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.1989.tb01353.x
– volume: 21
  start-page: 319
  year: 2014
  ident: 429_CR16
  publication-title: Chem Biol
  doi: 10.1016/j.chembiol.2013.12.016
– volume: 37
  start-page: 239
  year: 2013
  ident: 429_CR44
  publication-title: Am J Nephrol
  doi: 10.1159/000346846
– volume: 15
  start-page: 1316
  year: 2013
  ident: 429_CR26
  publication-title: Cell Cycle
  doi: 10.4161/cc.24445
– volume: 101
  start-page: 2454
  year: 2003
  ident: 429_CR118
  publication-title: Blood
  doi: 10.1182/blood-2002-07-1984
– volume: 142
  start-page: 482
  year: 2012
  ident: 429_CR8
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2011.11.040
– volume: 12
  start-page: 553
  year: 2002
  ident: 429_CR67
  publication-title: Eur J Dermatol
– volume: 42
  start-page: 361
  issue: 3
  year: 2014
  ident: 429_CR128
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.113.055673
– volume: 37
  start-page: 271
  year: 1994
  ident: 429_CR108
  publication-title: J Neurosci Res
  doi: 10.1002/jnr.490370212
– volume: 39
  start-page: 2611
  year: 2008
  ident: 429_CR121
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.107.513655
– volume: 70
  start-page: 243
  year: 1999
  ident: 429_CR65
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/S0960-0760(99)00112-0
– volume: 85
  start-page: 255
  year: 2007
  ident: 429_CR154
  publication-title: J Neurooncol
  doi: 10.1007/s11060-007-9418-z
– volume: 16
  start-page: 1
  year: 2010
  ident: 429_CR152
  publication-title: Cancer J
  doi: 10.1097/PPO.0b013e3181c51ee6
– volume: 88
  start-page: 286
  year: 2003
  ident: 429_CR75
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.10346
– volume: 66
  start-page: S73
  year: 2008
  ident: 429_CR39
  publication-title: Nutr Rev
  doi: 10.1111/j.1753-4887.2008.00105.x
– volume: 28
  start-page: 385
  year: 2006
  ident: 429_CR167
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2006.04.033
– volume: 121
  start-page: 408
  year: 2010
  ident: 429_CR78
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2010.03.053
– volume: 133
  start-page: 120
  year: 1999
  ident: 429_CR170
  publication-title: J Lab Clin Med
  doi: 10.1016/S0022-2143(99)90004-5
– volume: 29
  start-page: S22
  issue: Suppl. 29
  year: 1990
  ident: 429_CR21
  publication-title: Kidney Int
– volume: 37
  start-page: 115
  issue: 2
  year: 2009
  ident: 429_CR70
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2009.01.006
– volume: 130
  start-page: 2464
  year: 2012
  ident: 429_CR112
  publication-title: Int J Cancer
  doi: 10.1002/ijc.26279
– volume: 56
  start-page: 830
  year: 2011
  ident: 429_CR81
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-010-1544-3
– volume: 38
  start-page: 1732
  year: 2015
  ident: 429_CR169
  publication-title: Biol Pharm Bull
  doi: 10.1248/bpb.b15-00356
– volume: 116
  start-page: 3294
  year: 2010
  ident: 429_CR85
  publication-title: Cancer
  doi: 10.1002/cncr.25059
– volume: 141
  start-page: 274
  year: 1999
  ident: 429_CR9
  publication-title: Br J Dermatol
  doi: 10.1046/j.1365-2133.1999.02975.x
– volume: 26
  start-page: 852
  year: 1995
  ident: 429_CR141
  publication-title: Am J Kidney Dis
  doi: 10.1016/0272-6386(95)90455-7
– volume: 5
  start-page: 2502
  year: 2013
  ident: 429_CR123
  publication-title: Nutrients
  doi: 10.3390/nu5072502
– volume: 111
  start-page: 7
  year: 2010
  ident: 429_CR12
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.22661
– volume: 51
  start-page: 741
  issue: 5
  year: 1997
  ident: 429_CR132
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.51.5.741
– volume: 65
  start-page: 720
  issue: 3
  year: 2004
  ident: 429_CR45
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.65.3.720
– volume: 16
  start-page: 618
  year: 2007
  ident: 429_CR126
  publication-title: Exp Dermatol
  doi: 10.1111/j.1600-0625.2007.00570.x
– volume: 110
  start-page: 1605
  year: 1996
  ident: 429_CR68
  publication-title: Gastroenterology
  doi: 10.1053/gast.1996.v110.pm8613068
– volume: 143
  start-page: 1625
  year: 2002
  ident: 429_CR116
  publication-title: Endocrinology
  doi: 10.1210/endo.143.5.8777
– volume: 231
  start-page: 517
  issue: 3
  year: 1995
  ident: 429_CR23
  publication-title: Eur J Biochem
  doi: 10.1111/j.1432-1033.1995.tb20727.x
– volume: 27
  start-page: 1037
  year: 2012
  ident: 429_CR115
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2012.27.9.1037
– volume: 44
  start-page: 1431
  issue: 8
  year: 2016
  ident: 429_CR10
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.116.070300
– volume: 5
  start-page: 213
  year: 2014
  ident: 429_CR106
  publication-title: Front Physiol
  doi: 10.3389/fphys.2014.00213
– volume: 32
  start-page: S61
  year: 1998
  ident: 429_CR94
  publication-title: Am J Kidney Dis
  doi: 10.1053/ajkd.1998.v32.pm9808145
– volume: 139
  start-page: 1197
  year: 1998
  ident: 429_CR173
  publication-title: Endocrinology
  doi: 10.1210/endo.139.3.5770
– volume: 127
  start-page: 748
  year: 2007
  ident: 429_CR18
  publication-title: J Invest Dermatol
  doi: 10.1038/sj.jid.5700692
– volume: 1
  start-page: 1
  year: 1996
  ident: 429_CR64
  publication-title: J Investig Dermatol Symp Proc
– volume: 97
  start-page: 230
  year: 1991
  ident: 429_CR100
  publication-title: J Invest Dermatol
  doi: 10.1111/1523-1747.ep12480255
– volume: 136
  start-page: 83
  year: 2013
  ident: 429_CR103
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2013.02.005
– volume: 278
  start-page: 48030
  year: 2003
  ident: 429_CR66
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M308430200
– volume: 276
  start-page: 26365
  year: 2001
  ident: 429_CR97
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M010101200
– volume: 54
  start-page: 383
  year: 2015
  ident: 429_CR144
  publication-title: Int J Dermatol
  doi: 10.1111/ijd.12790
– volume: 33
  start-page: 713
  year: 2012
  ident: 429_CR138
  publication-title: Pediatr Cardiol
  doi: 10.1007/s00246-012-0199-6
– volume: 330
  start-page: 389
  year: 2009
  ident: 429_CR48
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.108.149815
– volume: 93
  start-page: 2225
  year: 1999
  ident: 429_CR104
  publication-title: Blood
  doi: 10.1182/blood.V93.7.2225
– volume: 29
  start-page: 691
  year: 2009
  ident: 429_CR109
  publication-title: Pharmacotherapy
  doi: 10.1592/phco.29.6.691
– volume: 50
  start-page: 999
  year: 1997
  ident: 429_CR53
  publication-title: Urology
  doi: 10.1016/S0090-4295(97)00408-1
– volume: 26
  start-page: 37
  year: 2012
  ident: 429_CR98
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2011-1109
– volume: 89
  start-page: 182
  year: 1997
  ident: 429_CR22
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/89.3.182
– volume: 44
  start-page: 693
  year: 1992
  ident: 429_CR35
  publication-title: Biochem Pharmacol
  doi: 10.1016/0006-2952(92)90405-8
– volume: 9
  start-page: 238
  year: 2005
  ident: 429_CR147
  publication-title: Clin Exp Nephrol
  doi: 10.1007/s10157-005-0363-x
– volume: 103
  start-page: 521
  year: 2007
  ident: 429_CR140
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2006.12.098
– volume: 25
  start-page: 130
  year: 2007
  ident: 429_CR52
  publication-title: J Bone Miner Metab
  doi: 10.1007/s00774-006-0738-4
– volume: 134
  start-page: 238
  year: 1996
  ident: 429_CR119
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.1996.tb07608.x
– volume: 144
  start-page: 500
  year: 2001
  ident: 429_CR43
  publication-title: Br J Dermatol
  doi: 10.1046/j.1365-2133.2001.04075.x
– volume: 2
  start-page: 9
  year: 2014
  ident: 429_CR60
  publication-title: Ann Transl Med
– volume: 1
  start-page: 97
  year: 1996
  ident: 429_CR89
  publication-title: J Investig Dermatol Symp Proc
– volume: 20
  start-page: 147
  year: 2014
  ident: 429_CR95
  publication-title: Mult Scler
  doi: 10.1177/1352458513494959
– volume: 324
  start-page: 23
  year: 2008
  ident: 429_CR38
  publication-title: Pharmacol Exp Ther
  doi: 10.1124/jpet.107.127209
– volume: 97
  start-page: 93
  year: 2005
  ident: 429_CR153
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2005.06.002
– volume: 6
  start-page: 727
  year: 1997
  ident: 429_CR134
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 262
  start-page: 2536
  year: 1987
  ident: 429_CR157
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)61537-6
– volume: 76
  start-page: 1017
  year: 1997
  ident: 429_CR36
  publication-title: Br J Cancer
  doi: 10.1038/bjc.1997.501
– volume: 79
  start-page: 1706
  year: 1987
  ident: 429_CR162
  publication-title: J Clin Invest
  doi: 10.1172/JCI113010
– volume: 277
  start-page: 25125
  issue: 28
  year: 2002
  ident: 429_CR42
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M201323200
– volume: 20
  start-page: 239
  year: 2009
  ident: 429_CR2
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-008-0650-y
– volume: 79
  start-page: 362
  year: 2004
  ident: 429_CR63
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/79.3.362
– volume: 133
  start-page: 2724
  year: 1993
  ident: 429_CR107
  publication-title: Endocrinology
  doi: 10.1210/endo.133.6.8243296
– volume: 79
  start-page: 360
  year: 2011
  ident: 429_CR143
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.110.068403
– volume: 6
  start-page: 284
  year: 1996
  ident: 429_CR50
  publication-title: Osteoporos Int
  doi: 10.1007/BF01623386
– volume: 30
  start-page: 457
  year: 2009
  ident: 429_CR27
  publication-title: Biopharm Drug Dispos
  doi: 10.1002/bdd.682
– volume: 253
  start-page: E675
  year: 1987
  ident: 429_CR161
  publication-title: Am J Physiol
– volume: 17
  start-page: 41
  issue: suppl 10
  year: 2002
  ident: 429_CR62
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/17.suppl_10.41
– volume: 26
  start-page: 429
  year: 2005
  ident: 429_CR105
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgh332
– volume: 46
  start-page: 149
  year: 2012
  ident: 429_CR88
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2012.02.018
– volume: 337
  start-page: 846
  year: 2011
  ident: 429_CR29
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.111.179101
– volume: 90
  start-page: 196
  year: 1991
  ident: 429_CR111
  publication-title: Contrib Nephrol
  doi: 10.1159/000420143
– volume: 55
  start-page: 821
  year: 1999
  ident: 429_CR102
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.1999.055003821.x
– volume: 5
  start-page: 122
  year: 2014
  ident: 429_CR82
  publication-title: Front Physiol
  doi: 10.3389/fphys.2014.00122
– volume: 95
  start-page: 896
  year: 2003
  ident: 429_CR76
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/95.12.896
– volume: 5
  start-page: 187
  year: 2012
  ident: 429_CR120
  publication-title: Ther Adv Neurol Disord
  doi: 10.1177/1756285612447090
– volume: 63
  start-page: 2020
  year: 2003
  ident: 429_CR142
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2003.00029.x
– volume: 41
  start-page: S108
  year: 2003
  ident: 429_CR168
  publication-title: Am J Kidney Dis
  doi: 10.1053/ajkd.2003.50097
– volume: 55
  start-page: 455
  issue: 3
  year: 2014
  ident: 429_CR25
  publication-title: J Lipid Res
  doi: 10.1194/jlr.M044420
– volume: 40
  start-page: 265
  year: 2013
  ident: 429_CR1
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.111594
– volume: 166
  start-page: 91
  year: 2015
  ident: 429_CR41
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000371350
– volume: 9
  start-page: 1427
  year: 1998
  ident: 429_CR93
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V981427
– volume: 60
  start-page: 1399
  year: 2001
  ident: 429_CR149
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.60.6.1399
– volume: 83
  start-page: 754
  year: 2006
  ident: 429_CR131
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/83.4.754
– volume: 103
  start-page: 3793
  year: 2014
  ident: 429_CR71
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24195
– volume: 141
  start-page: 2043
  year: 2000
  ident: 429_CR130
  publication-title: Endocrinology
  doi: 10.1210/endo.141.6.7515
– volume: 5
  start-page: 447
  year: 2006
  ident: 429_CR171
  publication-title: Cell Cycle
  doi: 10.4161/cc.5.4.2467
– volume: 32
  start-page: 112
  year: 2011
  ident: 429_CR87
  publication-title: Biopharm Drug Dispos
  doi: 10.1002/bdd.742
– volume: 56
  start-page: 383
  year: 1999
  ident: 429_CR129
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.1999.00575.x
– volume: 28
  start-page: 1877
  year: 2007
  ident: 429_CR3
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgm094
– volume: 15
  start-page: 301
  year: 2004
  ident: 429_CR127
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-003-1570-5
– volume: 179
  start-page: 57
  year: 1991
  ident: 429_CR37
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/0006-291X(91)91333-8
– volume: 160
  start-page: 247
  year: 1998
  ident: 429_CR51
  publication-title: J Urol
  doi: 10.1016/S0022-5347(01)63098-2
– volume: 85
  start-page: 198
  issue: 2
  year: 2009
  ident: 429_CR133
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2008.165
– volume: 8
  start-page: 480
  year: 2004
  ident: 429_CR6
  publication-title: Ther Apher Dial
  doi: 10.1111/j.1774-9987.2004.00191.x
– volume: 5
  start-page: 244
  year: 2014
  ident: 429_CR165
  publication-title: Front Physiol
– volume: 3
  start-page: 180
  year: 2011
  ident: 429_CR151
  publication-title: Dermatoendocrinol
  doi: 10.4161/derm.17534
– volume: 280
  start-page: 12
  year: 2015
  ident: 429_CR4
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2015.01.005
– volume: 288
  start-page: E125
  year: 2005
  ident: 429_CR166
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00224.2004
– volume: 65
  start-page: 705
  year: 2004
  ident: 429_CR150
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2004.00432.x
– volume: 157
  start-page: 168
  year: 2012
  ident: 429_CR13
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000323941
– volume: 69
  start-page: 1913
  year: 2006
  ident: 429_CR24
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.105.020792
– volume: 14
  start-page: 2975
  year: 2003
  ident: 429_CR46
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000093255.56474.B4
– volume: 103
  start-page: 533
  year: 2007
  ident: 429_CR110
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2006.12.099
– volume: 69
  start-page: 1740
  year: 2006
  ident: 429_CR174
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.105.019851
– volume: 122
  start-page: 1357
  year: 2004
  ident: 429_CR7
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.122.9.1357
– volume: 26
  start-page: 543
  year: 2012
  ident: 429_CR72
  publication-title: Fundam Clin Pharmacol
  doi: 10.1111/j.1472-8206.2011.00944.x
– volume: 6
  start-page: 468
  year: 2010
  ident: 429_CR137
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2010.86
– volume: 3
  start-page: 373
  year: 2004
  ident: 429_CR11
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.373.3.3
– volume: 59
  start-page: 24
  issue: Suppl 1
  year: 2000
  ident: 429_CR80
  publication-title: Z Rheumatol
  doi: 10.1007/s003930070034
– volume: 82
  start-page: 37
  year: 2012
  ident: 429_CR47
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.112.077909
– volume: 43
  start-page: 877
  issue: 5
  year: 2004
  ident: 429_CR33
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2004.01.012
– volume: 8
  start-page: 1787
  year: 2009
  ident: 429_CR15
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-09-0064
– volume: 146
  start-page: 414
  year: 2002
  ident: 429_CR156
  publication-title: Br J Dermatol
  doi: 10.1046/j.1365-2133.2002.04567.x
– volume: 178
  start-page: 54
  year: 2016
  ident: 429_CR160
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2016.07.006
– volume: 27
  start-page: 4467
  year: 2008
  ident: 429_CR117
  publication-title: Oncogene
  doi: 10.1038/onc.2008.88
– volume: 133
  start-page: 2425S
  year: 2003
  ident: 429_CR164
  publication-title: J Nutr
  doi: 10.1093/jn/133.7.2425S
– volume: 1
  start-page: 667
  year: 2002
  ident: 429_CR58
  publication-title: Mol Cancer Ther
– volume: 69
  start-page: 967
  year: 2009
  ident: 429_CR32
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-2307
– volume: 56
  start-page: 264
  year: 1996
  ident: 429_CR158
  publication-title: Cancer Res
– volume: 21
  start-page: 321
  year: 2001
  ident: 429_CR59
  publication-title: Anticancer Res
– volume: 17
  start-page: 1313
  year: 2002
  ident: 429_CR90
  publication-title: Science
  doi: 10.1126/science.1070477
– volume: 116
  start-page: 5535
  year: 2010
  ident: 429_CR136
  publication-title: Cancer
  doi: 10.1002/cncr.25478
– volume: 122
  start-page: 984
  year: 2004
  ident: 429_CR17
  publication-title: J Invest Dermatol
  doi: 10.1111/j.0022-202X.2004.22424.x
– volume: 258
  start-page: E134
  year: 1990
  ident: 429_CR163
  publication-title: Am J Physiol
– volume: 31
  start-page: 91
  year: 2010
  ident: 429_CR28
  publication-title: Biopharm Drug Dispos
  doi: 10.1002/bdd.694
– volume: 20
  start-page: 1742
  year: 2005
  ident: 429_CR69
  publication-title: J Bone Miner Res
  doi: 10.1359/JBMR.050605
– volume: 7
  start-page: 430
  year: 2008
  ident: 429_CR135
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.7.3.5418
– volume: 119
  start-page: 223
  year: 1988
  ident: 429_CR73
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.1988.tb03204.x
– volume: 39
  start-page: 99
  year: 2018
  ident: 429_CR124
  publication-title: Biopharm Drug Dispos
  doi: 10.1002/bdd.2118
– volume: 4
  start-page: 827
  year: 2008
  ident: 429_CR146
  publication-title: Ther Clin Risk Manag
  doi: 10.2147/TCRM.S3552
– volume: 280
  start-page: 23232
  issue: 24
  year: 2005
  ident: 429_CR96
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M411520200
– volume: 4
  start-page: 11
  year: 2004
  ident: 429_CR79
  publication-title: Exp Dermatol 13 Suppl
  doi: 10.1111/j.1600-0625.2004.00257.x
– volume: 87
  start-page: 214
  year: 2000
  ident: 429_CR91
  publication-title: Circ Res
  doi: 10.1161/01.RES.87.3.214
– volume: 17
  start-page: 28
  issue: Suppl. 10
  year: 2002
  ident: 429_CR5
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/17.suppl_10.28
– volume: 117
  start-page: 503
  year: 2008
  ident: 429_CR159
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.706127
– volume: 1
  start-page: iii2
  issue: Suppl 3
  year: 2008
  ident: 429_CR55
  publication-title: NDT Plus
– volume: 48
  start-page: 351
  year: 2013
  ident: 429_CR99
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2012.11.008
– volume: 3
  start-page: 237
  year: 2013
  ident: 429_CR172
  publication-title: Eur J Microbiol Immunol (Bp)
  doi: 10.1556/EuJMI.3.2013.4.1
– volume: 12
  start-page: 463
  year: 2002
  ident: 429_CR101
  publication-title: Eur J Dermatol
– volume: 103
  start-page: 416
  year: 2007
  ident: 429_CR125
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2006.12.081
– volume: 337
  start-page: 193
  year: 1991
  ident: 429_CR74
  publication-title: Lancet
  doi: 10.1016/0140-6736(91)92157-W
– volume: 164
  start-page: 133
  year: 2000
  ident: 429_CR145
  publication-title: Mol Cell Endocrinol
  doi: 10.1016/S0303-7207(00)00226-4
– volume: 279
  start-page: 25260
  year: 2004
  ident: 429_CR83
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M311052200
SSID ssj0000561889
Score 2.178397
SecondaryResourceType review_article
Snippet Vitamin D is involved in retaining the balance of several minerals in the body, such as calcium and phosphate, which are crucial for the bone formation and...
SourceID nrf
crossref
springer
SourceType Open Website
Enrichment Source
Index Database
Publisher
StartPage 1
SubjectTerms Biomedical and Life Sciences
Biomedicine
Review
약학
Title Therapeutic targets of vitamin D receptor ligands and their pharmacokinetic effects by modulation of transporters and metabolic enzymes
URI https://link.springer.com/article/10.1007/s40005-019-00429-z
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002552342
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Pharmaceutical Investigation, 2020, 50(1), , pp.1-16
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Pb9MwFLZod-ECTIAoPyZr4gaeiB3HzrECxgaCUyuNk_Xi2FPVNq3aDGn9B_i3eXacTsA0aZfkkmcltvP8ffZ73yPkba0UlBJKVnHvWC4-ACsFcIbEx2tAwKFi-tj3H8XZNP96IS9SUti2j3bvjySjp94nu-UBXyD1LVn0omw3IAcy06UekoPxl5_fbvZWAirWsfodR8LOpJQ85cvc3tBfa9Kg2fj_jkXjanP6mEz79-yCTOYnV211Ynf_SDje90OekEcJftJxN18OyQPXPCW_JzdJWLQLDd_Slae_Zi0sZw39RNEtujWyc7qYXYbcYIoXGs8Y6DppX88Rrgb7FCBCq2u6XNWpOFhord3LqG86-6VrcQYugk2zu1667TMyOf08-XjGUoEGZgWXLasBeKGKLANfWQ9a1w7pXAbCFhxKXVufW4UuxWlnhdWZKiqhvMitLEBKEM_JsFk17gWh3EsONWKzkIerPYCypcgKiwTd2RLqEcn6ETI2iZeHGhoLs5ddjr1qsFdN7FWzG5F3e5t1J91x59PHOPBmbmcmKG6H--XKzDcGecW5KYKMvxIj8r4fUpP-9e0dbb683-OvyEMe2Hzc4HlNhu3myr1ByNNWR2mGH5HBlI__AEJS-nM
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NbxMxELVoOMClagWIUEotxA0ssfZ67T1GLVECbU-p1Js167WrKMkmSpZKzR_o32bsOIsQqBKX3YvHh_HXe_a8GUI-1UpBKaFkFfeO5eIrsFIAZ0h8vAYEHCrKx66ui9FN_v1W3iZR2GYf7b5_kow7dSd2ywO-QOpbsriLsu0BeY5gQIe6BTd80N2sBEysY-07jnSdSSl5Usv8u5s_TqSDZu3_ehSNZ83wiBwmkEgHu1E9Js9c84o8Tn5LpegugHtDl57eI7tfTBt6QXHzcivk0HQ-vQsKXoofGl8C6CplqJ4hqAz2KYyDVg90saxTCa_QW9slO1_v7BeuxXkyDzbN9mHhNq_JZPhtcj5iqYwCs4LLltUAvFBFloGvrAeta4ekKwNhCw6lrq3PrcKF77SzwupMFZVQXuRWFiAliDek1ywb95ZQ7iWHGhFUUMtqD6BsKbLCIo12toS6T7K9J41NKcZDpYu56ZIjR-8b9L6J3jfbPvnc2ax2CTaebP0RB8jM7NSEvNjhf7c0s7VB9D82RUi2r0SffNmPn0krcvNEn-_-r_kZeTGaXF2ay_H1jxPykgf-Ha9k3pNeu_7pThGktNWHOCd_AWP53zM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NT-MwELX4kBAXxArQFthdC-0NLDZ2HCdHBFvxrT0UiZs1cWxUtU2rNiDRP8Df3rGThkWLkLgkF48PY3s8z_Z7Q8jPQinIJGQs586yWPwClgngDIGPSwETDhXoYze3yfldfHkv7_9h8YfX7osryZrT4FWayup4UrjjlvgW-1wDYXDGQkRl82WyiuE48jP9jp-0pyw-P05DHTyO0J1JKXnDnHm_mze703I5df9dkIZ9p7tJNpqEkZ7UI_yFLNlyi7z0XmlTtH7MPaNjR58Q6Y_6JT2jGMjsBPE0HfYfPJuX4oeGWwE6adSqB5hgevvmSQfNn-loXDTlvHxvVSt8Pq3tR7bCOTP0NuX8eWRn26TX_d07PWdNSQVmBJcVKwB4opIoApcbB2laWARgEQiTcMjSwrjYKAwCNrVGmDRSSS6UE7GRCUgJYoeslOPSfiWUO8mhwGzKM2dTB6BMJqLEIKS2JoOiQ6KFJ7Vp5MZ91YuhboWSg_c1el8H7-t5hxy2NpNabOPD1gc4QHpg-tprZPv_w1gPphqRwIVOvPC-Eh1ytBg_3azO2Qd97n6u-Q-y9uesq68vbq_2yDr3UDyczuyTlWr6aL9hvlLl38OU_As1SuNv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Therapeutic+targets+of+vitamin+D+receptor+ligands+and+their+pharmacokinetic+effects+by+modulation+of+transporters+and+metabolic+enzymes&rft.jtitle=Journal+of+pharmaceutical+investigation&rft.au=Choi%2C+Min+Sik&rft.au=Kim%2C+Yu+Chul&rft.au=Maeng%2C+Han-Joo&rft.date=2020-01-01&rft.issn=2093-5552&rft.eissn=2093-6214&rft.volume=50&rft.issue=1&rft.spage=1&rft.epage=16&rft_id=info:doi/10.1007%2Fs40005-019-00429-z&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s40005_019_00429_z
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-5552&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-5552&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-5552&client=summon